{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:06:22Z","timestamp":1791925582429,"version":"4.3.4"},"publisher-location":"Cham","reference-count":264,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783031230578","type":"print"},{"value":"9783031230585","type":"electronic"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1007\/7854_2022_347","type":"book-chapter","created":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T15:06:01Z","timestamp":1652281561000},"page":"157-201","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Current Perspectives on Selective Dopamine D3 Receptor Antagonists\/Partial Agonists as Pharmacotherapeutics for Opioid and Psychostimulant Use Disorders"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9065-4072","authenticated-orcid":false,"given":"Amy Hauck","family":"Newman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-Xiong","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Heidbreder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,12]]},"reference":[{"key":"347_CR1","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/S0306-4522(01)00317-7","volume":"106","author":"C Abbadie","year":"2001","unstructured":"Abbadie C, Pasternak GW, Aicher SA (2001) Presynaptic localization of the carboxy-terminus epitopes of the mu opioid receptor splice variants MOR-1C and MOR-1D in the superficial laminae of the rat spinal cord. Neuroscience 106:833\u2013842","journal-title":"Neuroscience"},{"key":"347_CR2","volume-title":"Provisional drug overdose death counts","author":"FB Ahmad","year":"2021","unstructured":"Ahmad FB, Rossen LM, Sutton P (2021) Provisional drug overdose death counts. National Center for Health Statistics. https:\/\/www.cdc.gov\/nchs\/nvss\/vsrr\/drug-overdose-data.htm"},{"key":"347_CR3","first-page":"208","volume":"285","author":"N Altier","year":"1998","unstructured":"Altier N, Stewart J (1998) Dopamine receptor antagonists in the nucleus accumbens attenuate analgesia induced by ventral tegmental area substance P or morphine and by nucleus accumbens amphetamine. J Pharmacol Exp Ther 285:208\u2013215","journal-title":"J Pharmacol Exp Ther"},{"key":"347_CR4","doi-asserted-by":"crossref","first-page":"2050313X1984182","DOI":"10.1177\/2050313X19841825","volume":"7","author":"BB Alves","year":"2019","unstructured":"Alves BB, Oliveira GP, Moreira Neto MG, Fiorilli RB, Cestario E (2019) Use of atypical antipsychotics and risk of hypertension: a case report and review literature. SAGE Open Med Case Rep 7:2050313X19841825","journal-title":"SAGE Open Med Case Rep"},{"key":"347_CR5","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1080\/14656566.2021.1931684","volume":"22","author":"GA Angarita","year":"2021","unstructured":"Angarita GA, Hadizadeh H, Cerdena I, Potenza MN (2021a) Can pharmacotherapy improve treatment outcomes in people with co-occurring major depressive and cocaine use disorders? Expert Opin Pharmacother 22:1669\u20131683","journal-title":"Expert Opin Pharmacother"},{"issue":"13","key":"347_CR6","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1080\/14656566.2021.1931684","volume":"22","author":"GA Angarita","year":"2021","unstructured":"Angarita GA, Hadizadeh H, Cerdena I, Potenza MN (2021b) Can pharmacotherapy improve treatment outcomes in people with co-occurring major depressive and cocaine use disorders? Expert Opin Pharmacother 22(13):1669\u20131683","journal-title":"Expert Opin Pharmacother"},{"key":"347_CR7","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1124\/jpet.115.224121","volume":"354","author":"NM Appel","year":"2015","unstructured":"Appel NM, Li SH, Holmes TH, Acri JB (2015) Dopamine D3 receptor antagonist (GSK598809) potentiates the hypertensive effects of cocaine in conscious, freely-moving dogs. J Pharmacol Exp Ther 354:484\u2013492","journal-title":"J Pharmacol Exp Ther"},{"key":"347_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.brainres.2007.04.043","volume":"1156","author":"KY Araki","year":"2007","unstructured":"Araki KY, Sims JR, Bhide PG (2007) Dopamine receptor mRNA and protein expression in the mouse corpus striatum and cerebral cortex during pre- and postnatal development. Brain Res 1156:31\u201345","journal-title":"Brain Res"},{"key":"347_CR9","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s004410050832","volume":"288","author":"E Asan","year":"1997","unstructured":"Asan E (1997) Ultrastructural features of tyrosine-hydroxylase-immunoreactive afferents and their targets in the rat amygdala. Cell Tissue Res 288:449\u2013469","journal-title":"Cell Tissue Res"},{"key":"347_CR10","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.nbd.2014.12.008","volume":"74","author":"A Avalos-Fuentes","year":"2015","unstructured":"Avalos-Fuentes A, Albarran-Bravo S, Loya-Lopez S, Cortes H, Recillas-Morales S, Magana JJ, Paz-Bermudez F, Rangel-Barajas C, Aceves J, Erlij D, Floran B (2015) Dopaminergic denervation switches dopamine D3 receptor signaling and disrupts its ca(2+) dependent modulation by CaMKII and calmodulin in striatonigral projections of the rat. Neurobiol Dis 74:336\u2013346","journal-title":"Neurobiol Dis"},{"key":"347_CR11","volume-title":"Opioid addiction","author":"M Azadfard","year":"2021","unstructured":"Azadfard M, Huecker MR, Leaming JM (2021) Opioid addiction. StatPearls, Treasure Island"},{"key":"347_CR12","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1124\/pr.110.002642","volume":"63","author":"JM Beaulieu","year":"2011","unstructured":"Beaulieu JM, Gainetdinov RR (2011) The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev 63:182\u2013217","journal-title":"Pharmacol Rev"},{"key":"347_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/bph.12906","volume":"172","author":"JM Beaulieu","year":"2015","unstructured":"Beaulieu JM, Espinoza S, Gainetdinov RR (2015) Dopamine receptors \u2013 IUPHAR review 13. Br J Pharmacol 172:1\u201323","journal-title":"Br J Pharmacol"},{"key":"347_CR14","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1017\/S1461145712000661","volume":"16","author":"J Bergman","year":"2013","unstructured":"Bergman J, Roof RA, Furman CA, Conroy JL, Mello NK, Sibley DR, Skolnick P (2013) Modification of cocaine self-administration by buspirone (buspar(R)): potential involvement of D3 and D4 dopamine receptors. Int J Neuropsychopharmacol 16:445\u2013458","journal-title":"Int J Neuropsychopharmacol"},{"key":"347_CR15","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1523\/JNEUROSCI.2382-18.2019","volume":"39","author":"AS Berry","year":"2019","unstructured":"Berry AS, White RL 3rd, Furman DJ, Naskolnakorn JR, Shah VD, D'Esposito M, Jagust WJ (2019) Dopaminergic mechanisms underlying normal variation in trait anxiety. J Neurosci 39:2735\u20132744","journal-title":"J Neurosci"},{"key":"347_CR16","doi-asserted-by":"publisher","first-page":"117252","DOI":"10.1016\/j.jns.2020.117252","volume":"420","author":"K Blum","year":"2021","unstructured":"Blum K, Cadet JL, Gold MS (2021a) Psychostimulant use disorder emphasizing methamphetamine and the opioid -dopamine connection: digging out of a hypodopaminergic ditch. J Neurol Sci 420:117252","journal-title":"J Neurol Sci"},{"key":"347_CR17","doi-asserted-by":"publisher","first-page":"623403","DOI":"10.3389\/fpsyt.2021.623403","volume":"12","author":"K Blum","year":"2021","unstructured":"Blum K, Khalsa J, Cadet JL, Baron D, Bowirrat A, Boyett B, Lott L, Brewer R, Gondre-Lewis M, Bunt G, Kazmi S, Gold MS (2021b) Cannabis-induced hypodopaminergic anhedonia and cognitive decline in humans: embracing putative induction of dopamine homeostasis. Front Psych 12:623403","journal-title":"Front Psych"},{"key":"347_CR18","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00210-008-0384-6","volume":"379","author":"S Bodei","year":"2009","unstructured":"Bodei S, Arrighi N, Spano P, Sigala S (2009) Should we be cautious on the use of commercially available antibodies to dopamine receptors? Naunyn Schmiedeberg\u2019s Arch Pharmacol 379:413\u2013415","journal-title":"Naunyn Schmiedeberg\u2019s Arch Pharmacol"},{"key":"347_CR19","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1038\/npp.2016.108","volume":"41","author":"I Boileau","year":"2016","unstructured":"Boileau I, Payer D, Rusjan PM, Houle S, Tong J, McCluskey T, Wilson AA, Kish SJ (2016) Heightened dopaminergic response to amphetamine at the D3 dopamine receptor in methamphetamine users. Neuropsychopharmacology 41:2994\u20133002","journal-title":"Neuropsychopharmacology"},{"key":"347_CR20","doi-asserted-by":"publisher","first-page":"7778","DOI":"10.1021\/acs.jmedchem.1c00611","volume":"64","author":"A Bonifazi","year":"2021","unstructured":"Bonifazi A, Battiti FO, Sanchez J, Zaidi SA, Bow E, Makarova M, Cao J, Shaik AB, Sulima A, Rice KC, Katritch V, Canals M, Lane JR, Newman AH (2021) Novel dual-target mu-opioid receptor and dopamine D3 receptor ligands as potential nonaddictive pharmacotherapeutics for pain management. J Med Chem 64:7778\u20137808","journal-title":"J Med Chem"},{"key":"347_CR21","doi-asserted-by":"publisher","first-page":"3363","DOI":"10.1073\/pnas.94.7.3363","volume":"94","author":"R Bordet","year":"1997","unstructured":"Bordet R, Ridray S, Carboni S, Diaz J, Sokoloff P, Schwartz JC (1997) Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa. Proc Natl Acad Sci U S A 94:3363\u20133367","journal-title":"Proc Natl Acad Sci U S A"},{"key":"347_CR22","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0006-8993(91)91456-B","volume":"564","author":"ML Bouthenet","year":"1991","unstructured":"Bouthenet ML, Souil E, Martres MP, Sokoloff P, Giros B, Schwartz JC (1991) Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA. Brain Res 564:203\u2013219","journal-title":"Brain Res"},{"key":"347_CR23","doi-asserted-by":"crossref","unstructured":"Bressan RA, Crippa JA (2005) The role of dopamine in reward and pleasure behaviour \u2013 review of data from preclinical research. Acta Psychiatr Scand Suppl (427):14\u201321","DOI":"10.1111\/j.1600-0447.2005.00540.x"},{"key":"347_CR24","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3389\/fncir.2014.00062","volume":"8","author":"KL Brewer","year":"2014","unstructured":"Brewer KL, Baran CA, Whitfield BR, Jensen AM, Clemens S (2014) Dopamine D3 receptor dysfunction prevents anti-nociceptive effects of morphine in the spinal cord. Front Neural Circuits 8:62","journal-title":"Front Neural Circuits"},{"key":"347_CR25","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.biopsych.2006.10.026","volume":"62","author":"AL Brody","year":"2007","unstructured":"Brody AL, Mandelkern MA, Olmstead RE, Jou J, Tiongson E, Allen V, Scheibal D, London ED, Monterosso JR, Tiffany ST, Korb A, Gan JJ, Cohen MS (2007) Neural substrates of resisting craving during cigarette cue exposure. Biol Psychiatry 62:642\u2013651","journal-title":"Biol Psychiatry"},{"key":"347_CR26","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/336783a0","volume":"336","author":"JR Bunzow","year":"1988","unstructured":"Bunzow JR, Van Tol HH, Grandy DK, Albert P, Salon J, Christie M, Machida CA, Neve KA, Civelli O (1988) Cloning and expression of a rat D2 dopamine receptor cDNA. Nature 336:783\u2013787","journal-title":"Nature"},{"key":"347_CR27","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/01.jcp.0000162804.38829.97","volume":"25","author":"L Buydens-Branchey","year":"2005","unstructured":"Buydens-Branchey L, Branchey M, Reel-Brander C (2005) Efficacy of buspirone in the treatment of opioid withdrawal. J Clin Psychopharmacol 25:230\u2013236","journal-title":"J Clin Psychopharmacol"},{"key":"347_CR28","first-page":"183","volume":"283","author":"JX Cai","year":"1997","unstructured":"Cai JX, Arnsten AF (1997) Dose-dependent effects of the dopamine D1 receptor agonists A77636 or SKF81297 on spatial working memory in aged monkeys. J Pharmacol Exp Ther 283:183\u2013189","journal-title":"J Pharmacol Exp Ther"},{"key":"347_CR29","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1016\/j.neuron.2021.06.011","volume":"109","author":"RR Campbell","year":"2021","unstructured":"Campbell RR, Lobo MK (2021) DRD3-dependent plasticity within the VP drives subcircuit activity critical for cocaine seeking. Neuron 109:2043\u20132044","journal-title":"Neuron"},{"key":"347_CR30","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S0889-8545(03)00079-2","volume":"30","author":"G Chander","year":"2003","unstructured":"Chander G, McCaul ME (2003) Co-occurring psychiatric disorders in women with addictions. Obstet Gynecol Clin N Am 30:469\u2013481","journal-title":"Obstet Gynecol Clin N Am"},{"key":"347_CR31","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/YCO.0000000000000717","volume":"34","author":"D Ciccarone","year":"2021","unstructured":"Ciccarone D (2021) The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis. Curr Opin Psychiatry 34:344\u2013350","journal-title":"Curr Opin Psychiatry"},{"key":"347_CR32","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1517\/17425255.2013.759211","volume":"9","author":"L Citrome","year":"2013","unstructured":"Citrome L (2013) Cariprazine: chemistry, pharmacodynamics, pharmacokinetics, and metabolism, clinical efficacy, safety, and tolerability. Expert Opin Drug Metab Toxicol 9:193\u2013206","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"347_CR33","doi-asserted-by":"publisher","first-page":"5846","DOI":"10.1523\/JNEUROSCI.0310-17.2017","volume":"37","author":"RL Clarkson","year":"2017","unstructured":"Clarkson RL, Liptak AT, Gee SM, Sohal VS, Bender KJ (2017) D3 receptors regulate excitability in a unique class of prefrontal pyramidal cells. J Neurosci 37:5846\u20135860","journal-title":"J Neurosci"},{"key":"347_CR34","doi-asserted-by":"publisher","first-page":"11337","DOI":"10.1523\/JNEUROSCI.3698-04.2004","volume":"24","author":"S Clemens","year":"2004","unstructured":"Clemens S, Hochman S (2004) Conversion of the modulatory actions of dopamine on spinal reflexes from depression to facilitation in D3 receptor knock-out mice. J Neurosci 24:11337\u201311345","journal-title":"J Neurosci"},{"key":"347_CR35","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1093\/cercor\/bhr354","volume":"22","author":"DM Cole","year":"2012","unstructured":"Cole DM, Beckmann CF, Searle GE, Plisson C, Tziortzi AC, Nichols TE, Gunn RN, Matthews PM, Rabiner EA, Beaver JD (2012) Orbitofrontal connectivity with resting-state networks is associated with midbrain dopamine D3 receptor availability. Cereb Cortex 22:2784\u20132793","journal-title":"Cereb Cortex"},{"key":"347_CR36","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1111\/j.1471-4159.2011.07618.x","volume":"120","author":"G Collo","year":"2012","unstructured":"Collo G, Bono F, Cavalleri L, Plebani L, Merlo Pich E, Millan MJ, Spano PF, Missale C (2012) Pre-synaptic dopamine D(3) receptor mediates cocaine-induced structural plasticity in mesencephalic dopaminergic neurons via ERK and Akt pathways. J Neurochem 120:765\u2013778","journal-title":"J Neurochem"},{"key":"347_CR37","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1001\/archpsyc.64.5.566","volume":"64","author":"WM Compton","year":"2007","unstructured":"Compton WM, Thomas YF, Stinson FS, Grant BF (2007) Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 64:566\u2013576","journal-title":"Arch Gen Psychiatry"},{"key":"347_CR38","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41380-020-00949-3","volume":"26","author":"WM Compton","year":"2021","unstructured":"Compton WM, Valentino RJ, DuPont RL (2021) Polysubstance use in the U.S. opioid crisis. Mol Psychiatry 26:41\u201350","journal-title":"Mol Psychiatry"},{"key":"347_CR39","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1126\/science.1145590","volume":"318","author":"M Contreras","year":"2007","unstructured":"Contreras M, Ceric F, Torrealba F (2007) Inactivation of the interoceptive insula disrupts drug craving and malaise induced by lithium. Science 318:655\u2013658","journal-title":"Science"},{"key":"347_CR40","doi-asserted-by":"publisher","first-page":"247","DOI":"10.4088\/JCP.v67n0211","volume":"67","author":"KP Conway","year":"2006","unstructured":"Conway KP, Compton W, Stinson FS, Grant BF (2006) Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 67:247\u2013257","journal-title":"J Clin Psychiatry"},{"key":"347_CR41","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s002130000520","volume":"152","author":"CD Cook","year":"2000","unstructured":"Cook CD, Barrett AC, Syvanthong C, Picker MJ (2000) The dopamine D3\/2 agonist 7-OH-DPAT attenuates the development of morphine tolerance but not physical dependence in rats. Psychopharmacology 152:93\u2013104","journal-title":"Psychopharmacology"},{"key":"347_CR42","doi-asserted-by":"publisher","first-page":"17024","DOI":"10.1038\/nrdp.2017.24","volume":"3","author":"MG Craske","year":"2017","unstructured":"Craske MG, Stein MB, Eley TC, Milad MR, Holmes A, Rapee RM, Wittchen HU (2017) Anxiety disorders. Nat Rev Dis Primers 3:17024","journal-title":"Nat Rev Dis Primers"},{"key":"347_CR43","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.neuron.2016.09.001","volume":"92","author":"M Creed","year":"2016","unstructured":"Creed M, Ntamati NR, Chandra R, Lobo MK, Luscher C (2016) Convergence of reinforcing and anhedonic cocaine effects in the ventral pallidum. Neuron 92:214\u2013226","journal-title":"Neuron"},{"key":"347_CR44","doi-asserted-by":"publisher","first-page":"17553","DOI":"10.3390\/ijms140917553","volume":"14","author":"S Cuevas","year":"2013","unstructured":"Cuevas S, Villar VA, Jose PA, Armando I (2013) Renal dopamine receptors, oxidative stress, and hypertension. Int J Mol Sci 14:17553\u201317572","journal-title":"Int J Mol Sci"},{"key":"347_CR45","doi-asserted-by":"publisher","first-page":"38746","DOI":"10.1038\/srep38746","volume":"6","author":"WL Dai","year":"2016","unstructured":"Dai WL, Xiong F, Yan B, Cao ZY, Liu WT, Liu JH, Yu BY (2016) Blockade of neuronal dopamine D2 receptor attenuates morphine tolerance in mice spinal cord. Sci Rep 6:38746","journal-title":"Sci Rep"},{"key":"347_CR46","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3389\/fnbeh.2019.00292","volume":"13","author":"G de Guglielmo","year":"2019","unstructured":"de Guglielmo G, Kallupi M, Sedighim S, Newman AH, George O (2019) Dopamine D3 receptor antagonism reverses the escalation of oxycodone self-administration and decreases withdrawal-induced hyperalgesia and irritability-like behavior in oxycodone-dependent heterogeneous stock rats. Front Behav Neurosci 13:292","journal-title":"Front Behav Neurosci"},{"key":"347_CR47","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/s41593-018-0151-z","volume":"21","author":"N Dedic","year":"2018","unstructured":"Dedic N, Kuhne C, Jakovcevski M, Hartmann J, Genewsky AJ, Gomes KS, Anderzhanova E, Pohlmann ML, Chang S, Kolarz A, Vogl AM, Dine J, Metzger MW, Schmid B, Almada RC, Ressler KJ, Wotjak CT, Grinevich V, Chen A, Schmidt MV, Wurst W, Refojo D, Deussing JM (2018) Chronic CRH depletion from GABAergic, long-range projection neurons in the extended amygdala reduces dopamine release and increases anxiety. Nat Neurosci 21:803\u2013807","journal-title":"Nat Neurosci"},{"key":"347_CR48","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.tins.2011.11.005","volume":"35","author":"A Der-Avakian","year":"2012","unstructured":"Der-Avakian A, Markou A (2012) The neurobiology of anhedonia and other reward-related deficits. Trends Neurosci 35:68\u201377","journal-title":"Trends Neurosci"},{"key":"347_CR49","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1111\/j.1460-9568.1994.tb00329.x","volume":"6","author":"J Diaz","year":"1994","unstructured":"Diaz J, Levesque D, Griffon N, Lammers CH, Martres MP, Sokoloff P, Schwartz JC (1994) Opposing roles for dopamine D2 and D3 receptors on neurotensin mRNA expression in nucleus accumbens. Eur J Neurosci 6:1384\u20131387","journal-title":"Eur J Neurosci"},{"key":"347_CR50","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/0306-4522(94)00527-C","volume":"65","author":"J Diaz","year":"1995","unstructured":"Diaz J, Levesque D, Lammers CH, Griffon N, Martres MP, Schwartz JC, Sokoloff P (1995) Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain. Neuroscience 65:731\u2013745","journal-title":"Neuroscience"},{"key":"347_CR51","doi-asserted-by":"publisher","first-page":"4282","DOI":"10.1523\/JNEUROSCI.17-11-04282.1997","volume":"17","author":"J Diaz","year":"1997","unstructured":"Diaz J, Ridray S, Mignon V, Griffon N, Schwartz JC, Sokoloff P (1997) Selective expression of dopamine D3 receptor mRNA in proliferative zones during embryonic development of the rat brain. J Neurosci 17:4282\u20134292","journal-title":"J Neurosci"},{"key":"347_CR52","doi-asserted-by":"publisher","first-page":"8677","DOI":"10.1523\/JNEUROSCI.20-23-08677.2000","volume":"20","author":"J Diaz","year":"2000","unstructured":"Diaz J, Pilon C, Le Foll B, Gros C, Triller A, Schwartz JC, Sokoloff P (2000) Dopamine D3 receptors expressed by all mesencephalic dopamine neurons. J Neurosci 20:8677\u20138684","journal-title":"J Neurosci"},{"key":"347_CR53","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.neulet.2018.03.006","volume":"691","author":"RK Doot","year":"2019","unstructured":"Doot RK, Dubroff JG, Labban KJ, Mach RH (2019) Selectivity of probes for PET imaging of dopamine D3 receptors. Neurosci Lett 691:18\u201325","journal-title":"Neurosci Lett"},{"key":"347_CR54","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1176\/appi.ajp.159.6.954","volume":"159","author":"DL Due","year":"2002","unstructured":"Due DL, Huettel SA, Hall WG, Rubin DC (2002) Activation in mesolimbic and visuospatial neural circuits elicited by smoking cues: evidence from functional magnetic resonance imaging. Am J Psychiatry 159:954\u2013960","journal-title":"Am J Psychiatry"},{"key":"347_CR55","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1080\/08897070802218554","volume":"29","author":"A Elkashef","year":"2008","unstructured":"Elkashef A, Vocci F, Hanson G, White J, Wickes W, Tiihonen J (2008) Pharmacotherapy of methamphetamine addiction: an update. Subst Abus 29:31\u201349","journal-title":"Subst Abus"},{"key":"347_CR56","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/npp.2014.18","volume":"39","author":"D Erritzoe","year":"2014","unstructured":"Erritzoe D, Tziortzi A, Bargiela D, Colasanti A, Searle GE, Gunn RN, Beaver JD, Waldman A, Nutt DJ, Bani M, Merlo-Pich E, Rabiner EA, Lingford-Hughes A (2014) In vivo imaging of cerebral dopamine D3 receptors in alcoholism. Neuropsychopharmacology 39:1703\u20131712","journal-title":"Neuropsychopharmacology"},{"key":"347_CR57","doi-asserted-by":"publisher","first-page":"e12988","DOI":"10.1111\/adb.12988","volume":"26","author":"ST Ewing","year":"2021","unstructured":"Ewing ST, Dorcely C, Maidi R, Paker G, Schelbaum E, Ranaldi R (2021) Low-dose polypharmacology targeting dopamine D1 and D3 receptors reduces cue-induced relapse to heroin seeking in rats. Addict Biol 26:e12988","journal-title":"Addict Biol"},{"key":"347_CR58","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1124\/mol.107.043885","volume":"74","author":"C Fiorentini","year":"2008","unstructured":"Fiorentini C, Busi C, Gorruso E, Gotti C, Spano P, Missale C (2008) Reciprocal regulation of dopamine D1 and D3 receptor function and trafficking by heterodimerization. Mol Pharmacol 74:59\u201369","journal-title":"Mol Pharmacol"},{"key":"347_CR59","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.coph.2009.09.008","volume":"10","author":"C Fiorentini","year":"2010","unstructured":"Fiorentini C, Busi C, Spano P, Missale C (2010) Dimerization of dopamine D1 and D3 receptors in the regulation of striatal function. Curr Opin Pharmacol 10:87\u201392","journal-title":"Curr Opin Pharmacol"},{"key":"347_CR60","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/JAN.0000000000000298","volume":"30","author":"SA Fogger","year":"2019","unstructured":"Fogger SA (2019) Methamphetamine use: a new wave in the opioid crisis? J Addict Nurs 30:219\u2013223","journal-title":"J Addict Nurs"},{"key":"347_CR61","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/S0278-5846(03)00081-2","volume":"27","author":"IH Franken","year":"2003","unstructured":"Franken IH (2003) Drug craving and addiction: integrating psychological and neuropsychopharmacological approaches. Prog Neuro-Psychopharmacol Biol Psychiatry 27:563\u2013579","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"347_CR62","doi-asserted-by":"publisher","first-page":"10652","DOI":"10.1038\/ncomms10652","volume":"7","author":"Z Freyberg","year":"2016","unstructured":"Freyberg Z, Sonders MS, Aguilar JI, Hiranita T, Karam CS, Flores J, Pizzo AB, Zhang Y, Farino ZJ, Chen A, Martin CA, Kopajtic TA, Fei H, Hu G, Lin YY, Mosharov EV, McCabe BD, Freyberg R, Wimalasena K, Hsin LW, Sames D, Krantz DE, Katz JL, Sulzer D, Javitch JA (2016) Mechanisms of amphetamine action illuminated through optical monitoring of dopamine synaptic vesicles in drosophila brain. Nat Commun 7:10652","journal-title":"Nat Commun"},{"key":"347_CR63","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S0306-4522(00)00092-0","volume":"97","author":"JL Fudge","year":"2000","unstructured":"Fudge JL, Haber SN (2000) The central nucleus of the amygdala projection to dopamine subpopulations in primates. Neuroscience 97:479\u2013494","journal-title":"Neuroscience"},{"key":"347_CR64","doi-asserted-by":"publisher","first-page":"173072","DOI":"10.1016\/j.pbb.2020.173072","volume":"200","author":"E Galaj","year":"2021","unstructured":"Galaj E, Xi ZX (2021) Progress in opioid reward research: from a canonical two-neuron hypothesis to two neural circuits. Pharmacol Biochem Behav 200:173072","journal-title":"Pharmacol Biochem Behav"},{"key":"347_CR65","doi-asserted-by":"publisher","first-page":"8853","DOI":"10.1523\/JNEUROSCI.0988-20.2020","volume":"40","author":"E Galaj","year":"2020","unstructured":"Galaj E, Han X, Shen H, Jordan CJ, He Y, Humburg B, Bi GH, Xi ZX (2020a) Dissecting the role of GABA neurons in the VTA versus SNr in opioid reward. J Neurosci 40:8853\u20138869","journal-title":"J Neurosci"},{"key":"347_CR66","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.neubiorev.2020.04.024","volume":"114","author":"E Galaj","year":"2020","unstructured":"Galaj E, Newman AH, Xi ZX (2020b) Dopamine D3 receptor-based medication development for the treatment of opioid use disorder: rationale, progress, and challenges. Neurosci Biobehav Rev 114:38\u201352","journal-title":"Neurosci Biobehav Rev"},{"key":"347_CR67","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/syn.21535","volume":"66","author":"JD Gallezot","year":"2012","unstructured":"Gallezot JD, Beaver JD, Gunn RN, Nabulsi N, Weinzimmer D, Singhal T, Slifstein M, Fowles K, Ding YS, Huang Y, Laruelle M, Carson RE, Rabiner EA (2012) Affinity and selectivity of [(1)(1)C]-(+)-PHNO for the D3 and D2 receptors in the rhesus monkey brain in vivo. Synapse 66:489\u2013500","journal-title":"Synapse"},{"key":"347_CR68","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1080\/105504900750047355","volume":"9","author":"EL Gardner","year":"2000","unstructured":"Gardner EL (2000) What we have learned about addiction from animal models of drug self-administration. Am J Addict 9:285\u2013313","journal-title":"Am J Addict"},{"key":"347_CR69","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1093\/ntr\/ntt172","volume":"16","author":"N Gaznick","year":"2014","unstructured":"Gaznick N, Tranel D, McNutt A, Bechara A (2014) Basal ganglia plus insula damage yields stronger disruption of smoking addiction than basal ganglia damage alone. Nicotine Tob Res 16:445\u2013453","journal-title":"Nicotine Tob Res"},{"key":"347_CR70","doi-asserted-by":"publisher","first-page":"7175","DOI":"10.1523\/JNEUROSCI.19-16-07175.1999","volume":"19","author":"RW Gear","year":"1999","unstructured":"Gear RW, Aley KO, Levine JD (1999) Pain-induced analgesia mediated by mesolimbic reward circuits. J Neurosci 19:7175\u20137181","journal-title":"J Neurosci"},{"key":"347_CR71","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1126\/science.2147780","volume":"250","author":"CR Gerfen","year":"1990","unstructured":"Gerfen CR, Engber TM, Mahan LC, Susel Z, Chase TN, Monsma FJ Jr, Sibley DR (1990) D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250:1429\u20131432","journal-title":"Science"},{"key":"347_CR72","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/sj.jcbfm.9600411","volume":"27","author":"N Ginovart","year":"2007","unstructured":"Ginovart N, Willeit M, Rusjan P, Graff A, Bloomfield PM, Houle S, Kapur S, Wilson AA (2007) Positron emission tomography quantification of [11C]-(+)-PHNO binding in the human brain. J Cereb Blood Flow Metab 27:857\u2013871","journal-title":"J Cereb Blood Flow Metab"},{"key":"347_CR73","first-page":"501","volume":"311","author":"B Giros","year":"1990","unstructured":"Giros B, Martres MP, Sokoloff P, Schwartz JC (1990) Gene cloning of human dopaminergic D3 receptor and identification of its chromosome. C R Acad Sci III 311:501\u2013508","journal-title":"C R Acad Sci III"},{"key":"347_CR74","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/ajad.13115","volume":"30","author":"SN Glick","year":"2021","unstructured":"Glick SN, Klein KS, Tinsley J, Golden MR (2021) Increasing heroin-methamphetamine (goofball) use and related morbidity among Seattle area people who inject drugs. Am J Addict 30:183\u2013191","journal-title":"Am J Addict"},{"key":"347_CR75","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1046\/j.1471-4159.1996.66052209.x","volume":"66","author":"A Gobert","year":"1996","unstructured":"Gobert A, Lejeune F, Rivet JM, Cistarelli L, Millan MJ (1996) Dopamine D3 (auto) receptors inhibit dopamine release in the frontal cortex of freely moving rats in vivo. J Neurochem 66:2209\u20132212","journal-title":"J Neurochem"},{"key":"347_CR76","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/0014-2999(89)90533-5","volume":"170","author":"AA Gomaa","year":"1989","unstructured":"Gomaa AA, Mohamed LH, Ahmed HN (1989) Modification of morphine-induced analgesia, tolerance and dependence by bromocriptine. Eur J Pharmacol 170:129\u2013135","journal-title":"Eur J Pharmacol"},{"key":"347_CR77","doi-asserted-by":"publisher","first-page":"e180217","DOI":"10.1001\/jamanetworkopen.2018.0217","volume":"1","author":"T Gomes","year":"2018","unstructured":"Gomes T, Tadrous M, Mamdani MM, Paterson JM, Juurlink DN (2018) The burden of opioid-related mortality in the United States. JAMA Netw Open 1:e180217","journal-title":"JAMA Netw Open"},{"key":"347_CR78","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/hbm.20392","volume":"29","author":"A Graff-Guerrero","year":"2008","unstructured":"Graff-Guerrero A, Willeit M, Ginovart N, Mamo D, Mizrahi R, Rusjan P, Vitcu I, Seeman P, Wilson AA, Kapur S (2008) Brain region binding of the D2\/3 agonist [11C]-(+)-PHNO and the D2\/3 antagonist [11C]raclopride in healthy humans. Hum Brain Mapp 29:400\u2013410","journal-title":"Hum Brain Mapp"},{"key":"347_CR79","doi-asserted-by":"publisher","first-page":"12040","DOI":"10.1073\/pnas.93.21.12040","volume":"93","author":"S Grant","year":"1996","unstructured":"Grant S, London ED, Newlin DB, Villemagne VL, Liu X, Contoreggi C, Phillips RL, Kimes AS, Margolin A (1996) Activation of memory circuits during cue-elicited cocaine craving. Proc Natl Acad Sci U S A 93:12040\u201312045","journal-title":"Proc Natl Acad Sci U S A"},{"key":"347_CR80","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.3390\/ijms22063100","volume":"22","author":"R Guerrero-Bautista","year":"2021","unstructured":"Guerrero-Bautista R, Franco-Garcia A, Hidalgo JM, Fernandez-Gomez FJ, Ribeiro Do Couto B, Milanes MV, Nunez C (2021) Distinct regulation of dopamine D3 receptor in the basolateral amygdala and dentate gyrus during the reinstatement of cocaine CPP induced by drug priming and social stress. Int J Mol Sci 22:3100","journal-title":"Int J Mol Sci"},{"key":"347_CR81","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/S0893-133X(98)00066-9","volume":"20","author":"EV Gurevich","year":"1999","unstructured":"Gurevich EV, Joyce JN (1999) Distribution of dopamine D3 receptor expressing neurons in the human forebrain: comparison with D2 receptor expressing neurons. Neuropsychopharmacology 20:60\u201380","journal-title":"Neuropsychopharmacology"},{"key":"347_CR82","first-page":"587","volume":"289","author":"EV Gurevich","year":"1999","unstructured":"Gurevich EV, Himes JW, Joyce JN (1999) Developmental regulation of expression of the D3 dopamine receptor in rat nucleus accumbens and islands of Calleja. J Pharmacol Exp Ther 289:587\u2013598","journal-title":"J Pharmacol Exp Ther"},{"key":"347_CR83","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1124\/jpet.106.107920","volume":"320","author":"I Gyertyan","year":"2007","unstructured":"Gyertyan I, Kiss B, Gal K, Laszlovszky I, Horvath A, Gemesi LI, Saghy K, Pasztor G, Zajer M, Kapas M, Csongor EA, Domany G, Tihanyi K, Szombathelyi Z (2007) Effects of RGH-237 [N-{4-[4-(3-aminocarbonyl-phenyl)-piperazin-1-yl]-butyl}-4-bromo-benzamide], an orally active, selective dopamine D(3) receptor partial agonist in animal models of cocaine abuse. J Pharmacol Exp Ther 320:1268\u20131278","journal-title":"J Pharmacol Exp Ther"},{"key":"347_CR84","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s002130050131","volume":"128","author":"H Hall","year":"1996","unstructured":"Hall H, Halldin C, Dijkstra D, Wikstrom H, Wise LD, Pugsley TA, Sokoloff P, Pauli S, Farde L, Sedvall G (1996) Autoradiographic localisation of D3-dopamine receptors in the human brain using the selective D3-dopamine receptor agonist (+)-[3H]PD 128907. Psychopharmacology 128:240\u2013247","journal-title":"Psychopharmacology"},{"key":"347_CR85","first-page":"121","volume":"293","author":"M He","year":"2000","unstructured":"He M, Shippenberg TS (2000) Strain differences in basal and cocaine-evoked dopamine dynamics in mouse striatum. J Pharmacol Exp Ther 293:121\u2013127","journal-title":"J Pharmacol Exp Ther"},{"key":"347_CR86","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1749-6632.2009.05149.x","volume":"1187","author":"CA Heidbreder","year":"2010","unstructured":"Heidbreder CA, Newman AH (2010) Current perspectives on selective dopamine D(3) receptor antagonists as pharmacotherapeutics for addictions and related disorders. Ann N Y Acad Sci 1187:4\u201334","journal-title":"Ann N Y Acad Sci"},{"key":"347_CR87","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/j.celrep.2020.01.023","volume":"30","author":"JA Heinsbroek","year":"2020","unstructured":"Heinsbroek JA, Bobadilla AC, Dereschewitz E, Assali A, Chalhoub RM, Cowan CW, Kalivas PW (2020) Opposing regulation of cocaine seeking by glutamate and GABA neurons in the ventral pallidum. Cell Rep 30:2018\u20132027.e2013","journal-title":"Cell Rep"},{"key":"347_CR88","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/JAN.0000000000000058","volume":"26","author":"TL Hellem","year":"2015","unstructured":"Hellem TL, Lundberg KJ, Renshaw PF (2015) A review of treatment options for co-occurring methamphetamine use disorders and depression. J Addict Nurs 26:14\u201323; quiz E11","journal-title":"J Addict Nurs"},{"key":"347_CR89","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/0006-8993(94)91121-5","volume":"648","author":"L Herroelen","year":"1994","unstructured":"Herroelen L, De Backer JP, Wilczak N, Flamez A, Vauquelin G, De Keyser J (1994) Autoradiographic distribution of D3-type dopamine receptors in human brain using [3H]7-hydroxy-N,N-di-n-propyl-2-aminotetralin. Brain Res 648:222\u2013228","journal-title":"Brain Res"},{"key":"347_CR90","doi-asserted-by":"publisher","first-page":"656475","DOI":"10.3389\/fnins.2021.656475","volume":"15","author":"M Hersey","year":"2021","unstructured":"Hersey M, Bacon AK, Bailey LG, Coggiano MA, Newman AH, Leggio L, Tanda G (2021) Psychostimulant use disorder, an unmet therapeutic goal: can modafinil narrow the gap? Front Neurosci 15:656475","journal-title":"Front Neurosci"},{"key":"347_CR91","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1073\/pnas.1220358110","volume":"110","author":"T Hikida","year":"2013","unstructured":"Hikida T, Yawata S, Yamaguchi T, Danjo T, Sasaoka T, Wang Y, Nakanishi S (2013) Pathway-specific modulation of nucleus accumbens in reward and aversive behavior via selective transmitter receptors. Proc Natl Acad Sci U S A 110:342\u2013347","journal-title":"Proc Natl Acad Sci U S A"},{"key":"347_CR92","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1124\/jpet.119.259879","volume":"371","author":"M Huang","year":"2019","unstructured":"Huang M, He W, Kiss B, Farkas B, Adham N, Meltzer HY (2019) The role of dopamine D3 receptor partial agonism in cariprazine-induced neurotransmitter efflux in rat hippocampus and nucleus accumbens. J Pharmacol Exp Ther 371:517\u2013525","journal-title":"J Pharmacol Exp Ther"},{"key":"347_CR93","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.neuron.2009.02.001","volume":"61","author":"TC Jhou","year":"2009","unstructured":"Jhou TC, Fields HL, Baxter MG, Saper CB, Holland PC (2009) The rostromedial tegmental nucleus (RMTg), a GABAergic afferent to midbrain dopamine neurons, encodes aversive stimuli and inhibits motor responses. Neuron 61:786\u2013800","journal-title":"Neuron"},{"key":"347_CR94","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.drugalcdep.2018.11.011","volume":"194","author":"WS John","year":"2019","unstructured":"John WS, Zhu H, Mannelli P, Subramaniam GA, Schwartz RP, McNeely J, Wu LT (2019) Prevalence and patterns of opioid misuse and opioid use disorder among primary care patients who use tobacco. Drug Alcohol Depend 194:468\u2013475","journal-title":"Drug Alcohol Depend"},{"key":"347_CR95","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1001\/jama.2018.2844","volume":"319","author":"CM Jones","year":"2018","unstructured":"Jones CM, Einstein EB, Compton WM (2018) Changes in synthetic opioid involvement in drug overdose deaths in the United States, 2010-2016. JAMA 319:1819\u20131821","journal-title":"JAMA"},{"key":"347_CR96","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1093\/epirev\/mxaa011","volume":"42","author":"CM Jones","year":"2020","unstructured":"Jones CM, Bekheet F, Park JN, Alexander GC (2020) The evolving overdose epidemic: synthetic opioids and rising stimulant-related harms. Epidemiol Rev 42:154\u2013166","journal-title":"Epidemiol Rev"},{"key":"347_CR97","doi-asserted-by":"publisher","first-page":"107597","DOI":"10.1016\/j.neuropharm.2019.04.003","volume":"158","author":"CJ Jordan","year":"2019","unstructured":"Jordan CJ, Humburg B, Rice M, Bi GH, You ZB, Shaik AB, Cao J, Bonifazi A, Gadiano A, Rais R, Slusher B, Newman AH, Xi ZX (2019a) The highly selective dopamine D3R antagonist, R-VK4-40 attenuates oxycodone reward and augments analgesia in rodents. Neuropharmacology 158:107597","journal-title":"Neuropharmacology"},{"key":"347_CR98","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1124\/jpet.119.259390","volume":"371","author":"CJ Jordan","year":"2019","unstructured":"Jordan CJ, Humburg BA, Thorndike EB, Shaik AB, Xi ZX, Baumann MH, Newman AH, Schindler CW (2019b) Newly developed dopamine D3 receptor antagonists, R-VK4-40 and R-VK4-116, do not potentiate cardiovascular effects of cocaine or oxycodone in rats. J Pharmacol Exp Ther 371:602\u2013614","journal-title":"J Pharmacol Exp Ther"},{"key":"347_CR99","doi-asserted-by":"publisher","first-page":"4796","DOI":"10.1111\/bph.15244","volume":"177","author":"CJ Jordan","year":"2020","unstructured":"Jordan CJ, He Y, Bi GH, You ZB, Cao J, Xi ZX, Newman AH (2020) (+\/\u2212)VK4-40, a novel dopamine D3 receptor partial agonist, attenuates cocaine reward and relapse in rodents. Br J Pharmacol 177:4796\u20134807","journal-title":"Br J Pharmacol"},{"key":"347_CR100","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3109\/10641969709080801","volume":"19","author":"PA Jose","year":"1997","unstructured":"Jose PA, Drago J, Accili D, Eisner GM, Felder RA (1997) Transgenic mice to study the role of dopamine receptors in cardiovascular function. Clin Exp Hypertens 19:15\u201325","journal-title":"Clin Exp Hypertens"},{"key":"347_CR101","doi-asserted-by":"publisher","first-page":"592","DOI":"10.3389\/fpsyt.2019.00592","volume":"10","author":"J Kakko","year":"2019","unstructured":"Kakko J, Alho H, Baldacchino A, Molina R, Nava FA, Shaya G (2019) Craving in opioid use disorder: from neurobiology to clinical practice. Front Psych 10:592","journal-title":"Front Psych"},{"key":"347_CR102","doi-asserted-by":"publisher","first-page":"5506","DOI":"10.1523\/JNEUROSCI.0292-04.2004","volume":"24","author":"NH Kalin","year":"2004","unstructured":"Kalin NH, Shelton SE, Davidson RJ (2004) The role of the central nucleus of the amygdala in mediating fear and anxiety in the primate. J Neurosci 24:5506\u20135515","journal-title":"J Neurosci"},{"key":"347_CR103","unstructured":"Kampman K (2021) Cariprazine for comorbid cocaine and opioid use didorder. ClinicalTrials.Gov NCT05063201. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05063201?term=cariprazine+and+cocaine&draw=05063202&rank=05063201"},{"key":"347_CR104","doi-asserted-by":"publisher","first-page":"5361","DOI":"10.1021\/jm501512b","volume":"58","author":"TM Keck","year":"2015","unstructured":"Keck TM, John WS, Czoty PW, Nader MA, Newman AH (2015) Identifying medication targets for psychostimulant addiction: unraveling the dopamine D3 receptor hypothesis. J Med Chem 58:5361\u20135380","journal-title":"J Med Chem"},{"key":"347_CR105","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.expneurol.2012.09.002","volume":"238","author":"BE Keeler","year":"2012","unstructured":"Keeler BE, Baran CA, Brewer KL, Clemens S (2012) Increased excitability of spinal pain reflexes and altered frequency-dependent modulation in the dopamine D3-receptor knockout mouse. Exp Neurol 238:273\u2013283","journal-title":"Exp Neurol"},{"key":"347_CR106","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s10571-020-01013-y","volume":"41","author":"C Kibaly","year":"2021","unstructured":"Kibaly C, Alderete JA, Liu SH, Nasef HS, Law PY, Evans CJ, Cahill CM (2021) Oxycodone in the opioid epidemic: high \u2018liking\u2019, \u2018wanting\u2019, and abuse liability. Cell Mol Neurobiol 41:899\u2013926","journal-title":"Cell Mol Neurobiol"},{"key":"347_CR107","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1038\/nn.2222","volume":"11","author":"T Kienast","year":"2008","unstructured":"Kienast T, Hariri AR, Schlagenhauf F, Wrase J, Sterzer P, Buchholz HG, Smolka MN, Grunder G, Cumming P, Kumakura Y, Bartenstein P, Dolan RJ, Heinz A (2008) Dopamine in amygdala gates limbic processing of aversive stimuli in humans. Nat Neurosci 11:1381\u20131382","journal-title":"Nat Neurosci"},{"key":"347_CR108","doi-asserted-by":"publisher","first-page":"37409","DOI":"10.1074\/jbc.M106728200","volume":"276","author":"KM Kim","year":"2001","unstructured":"Kim KM, Valenzano KJ, Robinson SR, Yao WD, Barak LS, Caron MG (2001) Differential regulation of the dopamine D2 and D3 receptors by G protein-coupled receptor kinases and beta-arrestins. J Biol Chem 276:37409\u201337414","journal-title":"J Biol Chem"},{"key":"347_CR109","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1124\/jpet.109.160432","volume":"333","author":"B Kiss","year":"2010","unstructured":"Kiss B, Horvath A, Nemethy Z, Schmidt E, Laszlovszky I, Bugovics G, Fazekas K, Hornok K, Orosz S, Gyertyan I, Agai-Csongor E, Domany G, Tihanyi K, Adham N, Szombathelyi Z (2010) Cariprazine (RGH-188), a dopamine D(3) receptor-preferring, D(3)\/D(2) dopamine receptor antagonist-partial agonist antipsychotic candidate: in vitro and neurochemical profile. J Pharmacol Exp Ther 333:328\u2013340","journal-title":"J Pharmacol Exp Ther"},{"key":"347_CR110","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/syn.20867","volume":"65","author":"B Kiss","year":"2011","unstructured":"Kiss B, Horti F, Bobok A (2011) In vitro and in vivo comparison of [(3)H](+)-PHNO and [(3)H]raclopride binding to rat striatum and lobes 9 and 10 of the cerebellum: a method to distinguish dopamine D(3) from D(2) receptor sites. Synapse 65:467\u2013478","journal-title":"Synapse"},{"key":"347_CR111","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1001\/jamapsychiatry.2019.1839","volume":"76","author":"BA Kleykamp","year":"2019","unstructured":"Kleykamp BA, Weiss RD, Strain EC (2019) Time to reconsider the role of craving in opioid use disorder. JAMA Psychiat 76:1113\u20131114","journal-title":"JAMA Psychiat"},{"key":"347_CR112","doi-asserted-by":"publisher","first-page":"117270","DOI":"10.1016\/j.neuroimage.2020.117270","volume":"223","author":"A Komorowski","year":"2020","unstructured":"Komorowski A, Weidenauer A, Murgas M, Sauerzopf U, Wadsak W, Mitterhauser M, Bauer M, Hacker M, Praschak-Rieder N, Kasper S, Lanzenberger R, Willeit M (2020) Association of dopamine D2\/3 receptor binding potential measured using PET and [(11)C]-(+)-PHNO with post-mortem DRD2\/3 gene expression in the human brain. NeuroImage 223:117270","journal-title":"NeuroImage"},{"key":"347_CR113","first-page":"72","volume":"4","author":"GF Koob","year":"2013","unstructured":"Koob GF (2013) Addiction is a reward deficit and stress surfeit disorder. Front Psych 4:72","journal-title":"Front Psych"},{"key":"347_CR114","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1124\/pharmrev.120.000083","volume":"73","author":"GF Koob","year":"2021","unstructured":"Koob GF (2021) Drug addiction: hyperkatifeia\/negative reinforcement as a framework for medications development. Pharmacol Rev 73:163\u2013201","journal-title":"Pharmacol Rev"},{"key":"347_CR115","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1126\/science.2903550","volume":"242","author":"GF Koob","year":"1988","unstructured":"Koob GF, Bloom FE (1988) Cellular and molecular mechanisms of drug dependence. Science 242:715\u2013723","journal-title":"Science"},{"key":"347_CR116","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/nn.3100","volume":"15","author":"AV Kravitz","year":"2012","unstructured":"Kravitz AV, Tye LD, Kreitzer AC (2012) Distinct roles for direct and indirect pathway striatal neurons in reinforcement. Nat Neurosci 15:816\u2013818","journal-title":"Nat Neurosci"},{"key":"347_CR117","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/BF02090784","volume":"14","author":"NS Kula","year":"1994","unstructured":"Kula NS, Baldessarini RJ, Kebabian JW, Neumeyer JL (1994) S-(+)-aporphines are not selective for human D3 dopamine receptors. Cell Mol Neurobiol 14:185\u2013191","journal-title":"Cell Mol Neurobiol"},{"key":"347_CR118","doi-asserted-by":"publisher","first-page":"7634","DOI":"10.1021\/acs.jmedchem.6b00860","volume":"59","author":"V Kumar","year":"2016","unstructured":"Kumar V, Bonifazi A, Ellenberger MP, Keck TM, Pommier E, Rais R, Slusher BS, Gardner E, You ZB, Xi ZX, Newman AH (2016) Highly selective dopamine D3 receptor (D3R) antagonists and partial agonists based on eticlopride and the D3R crystal structure: new leads for opioid dependence treatment. J Med Chem 59:7634\u20137650","journal-title":"J Med Chem"},{"key":"347_CR119","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pnpbp.2013.12.018","volume":"51","author":"SC Kuo","year":"2014","unstructured":"Kuo SC, Yeh YW, Chen CY, Huang CC, Chang HA, Yen CH, Ho PS, Liang CS, Chou HW, Lu RB, Huang SY (2014) DRD3 variation associates with early-onset heroin dependence, but not specific personality traits. Prog Neuro-Psychopharmacol Biol Psychiatry 51:1\u20138","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"347_CR120","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/sj.npp.1300114","volume":"28","author":"LP Lacroix","year":"2003","unstructured":"Lacroix LP, Hows ME, Shah AJ, Hagan JJ, Heidbreder CA (2003) Selective antagonism at dopamine D3 receptors enhances monoaminergic and cholinergic neurotransmission in the rat anterior cingulate cortex. Neuropsychopharmacology 28:839\u2013849","journal-title":"Neuropsychopharmacology"},{"key":"347_CR121","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.neuropharm.2013.03.019","volume":"76 Pt B","author":"S Lammel","year":"2014","unstructured":"Lammel S, Lim BK, Malenka RC (2014) Reward and aversion in a heterogeneous midbrain dopamine system. Neuropharmacology 76 Pt B:351\u2013359","journal-title":"Neuropharmacology"},{"key":"347_CR122","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/sj.mp.4000756","volume":"5","author":"CH Lammers","year":"2000","unstructured":"Lammers CH, Diaz J, Schwartz JC, Sokoloff P (2000) Dopamine D3 receptor gene expression in the shell of nucleus accumbens is increased by chronic antidepressant treatment. Mol Psychiatry 5:229","journal-title":"Mol Psychiatry"},{"key":"347_CR123","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1460-9568.1993.tb00480.x","volume":"5","author":"B Landwehrmeyer","year":"1993","unstructured":"Landwehrmeyer B, Mengod G, Palacios JM (1993a) Differential visualization of dopamine D2 and D3 receptor sites in rat brain. A comparative study using in situ hybridization histochemistry and ligand binding autoradiography. Eur J Neurosci 5:145\u2013153","journal-title":"Eur J Neurosci"},{"key":"347_CR124","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/0169-328X(93)90188-U","volume":"18","author":"B Landwehrmeyer","year":"1993","unstructured":"Landwehrmeyer B, Mengod G, Palacios JM (1993b) Dopamine D3 receptor mRNA and binding sites in human brain. Brain Res Mol Brain Res 18:187\u2013192","journal-title":"Brain Res Mol Brain Res"},{"key":"347_CR125","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/syn.890200406","volume":"20","author":"ER Larson","year":"1995","unstructured":"Larson ER, Ariano MA (1995) D3 and D2 dopamine receptors: visualization of cellular expression patterns in motor and limbic structures. Synapse 20:325\u2013337","journal-title":"Synapse"},{"key":"347_CR126","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/npp.2015.177","volume":"41","author":"B Le Foll","year":"2016","unstructured":"Le Foll B, Payer D, Di Ciano P, Guranda M, Nakajima S, Tong J, Mansouri E, Wilson AA, Houle S, Meyer JH, Graff-Guerrero A, Boileau I (2016) Occupancy of dopamine D3 and D2 receptors by buspirone: a [11C]-(+)-PHNO PET study in humans. Neuropsychopharmacology 41:529\u2013537","journal-title":"Neuropsychopharmacology"},{"key":"347_CR127","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0306-4522(96)00029-2","volume":"73","author":"C Le Moine","year":"1996","unstructured":"Le Moine C, Bloch B (1996) Expression of the D3 dopamine receptor in peptidergic neurons of the nucleus accumbens: comparison with the D1 and D2 dopamine receptors. Neuroscience 73:131\u2013143","journal-title":"Neuroscience"},{"key":"347_CR128","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.pharmthera.2016.06.007","volume":"165","author":"GM Leggio","year":"2016","unstructured":"Leggio GM, Bucolo C, Platania CB, Salomone S, Drago F (2016) Current drug treatments targeting dopamine D3 receptor. Pharmacol Ther 165:164\u2013177","journal-title":"Pharmacol Ther"},{"key":"347_CR129","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1601-183X.2007.00356.x","volume":"7","author":"HM Lesscher","year":"2008","unstructured":"Lesscher HM, McMahon T, Lasek AW, Chou WH, Connolly J, Kharazia V, Messing RO (2008) Amygdala protein kinase C epsilon regulates corticotropin-releasing factor and anxiety-like behavior. Genes Brain Behav 7:323\u2013333","journal-title":"Genes Brain Behav"},{"key":"347_CR130","first-page":"231","volume":"49","author":"B Levant","year":"1997","unstructured":"Levant B (1997) The D3 dopamine receptor: neurobiology and potential clinical relevance. Pharmacol Rev 49:231\u2013252","journal-title":"Pharmacol Rev"},{"key":"347_CR131","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0006-8993(98)00529-0","volume":"800","author":"B Levant","year":"1998","unstructured":"Levant B (1998) Differential distribution of D3 dopamine receptors in the brains of several mammalian species. Brain Res 800:269\u2013274","journal-title":"Brain Res"},{"key":"347_CR132","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0304-3940(01)01692-5","volume":"303","author":"B Levant","year":"2001","unstructured":"Levant B, McCarson KE (2001) D(3) dopamine receptors in rat spinal cord: implications for sensory and motor function. Neurosci Lett 303:9\u201312","journal-title":"Neurosci Lett"},{"key":"347_CR133","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1080\/10550490600860148","volume":"15","author":"AM Leventhal","year":"2006","unstructured":"Leventhal AM, Mooney ME, DeLaune KA, Schmitz JM (2006) Using addiction severity profiles to differentiate cocaine-dependent patients with and without comorbid major depression. Am J Addict 15:362\u2013369","journal-title":"Am J Addict"},{"key":"347_CR134","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1073\/pnas.92.5.1719","volume":"92","author":"D Levesque","year":"1995","unstructured":"Levesque D, Martres MP, Diaz J, Griffon N, Lammers CH, Sokoloff P, Schwartz JC (1995) A paradoxical regulation of the dopamine D3 receptor expression suggests the involvement of an anterograde factor from dopamine neurons. Proc Natl Acad Sci U S A 92:1719\u20131723","journal-title":"Proc Natl Acad Sci U S A"},{"key":"347_CR135","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.tips.2014.04.002","volume":"35","author":"M Leyton","year":"2014","unstructured":"Leyton M, Vezina P (2014) Dopamine ups and downs in vulnerability to addictions: a neurodevelopmental model. Trends Pharmacol Sci 35:268\u2013276","journal-title":"Trends Pharmacol Sci"},{"key":"347_CR136","doi-asserted-by":"publisher","first-page":"13248","DOI":"10.1523\/JNEUROSCI.3027-08.2008","volume":"28","author":"YQ Li","year":"2008","unstructured":"Li YQ, Li FQ, Wang XY, Wu P, Zhao M, Xu CM, Shaham Y, Lu L (2008) Central amygdala extracellular signal-regulated kinase signaling pathway is critical to incubation of opiate craving. J Neurosci 28:13248\u201313257","journal-title":"J Neurosci"},{"key":"347_CR137","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1111\/add.13375","volume":"111","author":"W Ling","year":"2016","unstructured":"Ling W, Hillhouse MP, Saxon AJ, Mooney LJ, Thomas CM, Ang A, Matthews AG, Hasson A, Annon J, Sparenborg S, Liu DS, McCormack J, Church S, Swafford W, Drexler K, Schuman C, Ross S, Wiest K, Korthuis PT, Lawson W, Brigham GS, Knox PC, Dawes M, Rotrosen J (2016) Buprenorphine + naloxone plus naltrexone for the treatment of cocaine dependence: the cocaine use reduction with buprenorphine (CURB) study. Addiction 111:1416\u20131427","journal-title":"Addiction"},{"key":"347_CR138","doi-asserted-by":"publisher","first-page":"106142","DOI":"10.1016\/j.addbeh.2019.106142","volume":"101","author":"S Liu","year":"2020","unstructured":"Liu S, Vivolo-Kantor A (2020) A latent class analysis of drug and substance use patterns among patients treated in emergency departments for suspected drug overdose. Addict Behav 101:106142","journal-title":"Addict Behav"},{"key":"347_CR139","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.neuron.2008.12.015","volume":"61","author":"XY Liu","year":"2009","unstructured":"Liu XY, Mao LM, Zhang GC, Papasian CJ, Fibuch EE, Lan HX, Zhou HF, Xu M, Wang JQ (2009) Activity-dependent modulation of limbic dopamine D3 receptors by CaMKII. Neuron 61:425\u2013438","journal-title":"Neuron"},{"key":"347_CR140","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1126\/science.1188472","volume":"330","author":"MK Lobo","year":"2010","unstructured":"Lobo MK, Covington HE 3rd, Chaudhury D, Friedman AK, Sun H, Damez-Werno D, Dietz DM, Zaman S, Koo JW, Kennedy PJ, Mouzon E, Mogri M, Neve RL, Deisseroth K, Han MH, Nestler EJ (2010) Cell type-specific loss of BDNF signaling mimics optogenetic control of cocaine reward. Science 330:385\u2013390","journal-title":"Science"},{"key":"347_CR141","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/nn1383","volume":"8","author":"L Lu","year":"2005","unstructured":"Lu L, Hope BT, Dempsey J, Liu SY, Bossert JM, Shaham Y (2005) Central amygdala ERK signaling pathway is critical to incubation of cocaine craving. Nat Neurosci 8:212\u2013219","journal-title":"Nat Neurosci"},{"key":"347_CR142","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.tins.2021.06.009","volume":"44","author":"C Luscher","year":"2021","unstructured":"Luscher C, Pascoli V (2021) \u2018Ups, downs, and sideways\u2019 of dopamine in drug addiction. Trends Neurosci 44:593\u2013594","journal-title":"Trends Neurosci"},{"key":"347_CR143","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41401-018-0153-0","volume":"40","author":"Y Lv","year":"2019","unstructured":"Lv Y, Hu RR, Jing M, Zhao TY, Wu N, Song R, Li J, Hu G (2019) Selective dopamine D3 receptor antagonist YQA14 inhibits morphine-induced behavioral sensitization in wild type, but not in dopamine D3 receptor knockout mice. Acta Pharmacol Sin 40:583\u2013588","journal-title":"Acta Pharmacol Sin"},{"key":"347_CR144","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1053\/j.semperi.2019.01.001","volume":"43","author":"J Lyden","year":"2019","unstructured":"Lyden J, Binswanger IA (2019) The United States opioid epidemic. Semin Perinatol 43:123\u2013131","journal-title":"Semin Perinatol"},{"key":"347_CR145","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/j.1530-0277.1996.tb01644.x","volume":"20","author":"E Malec","year":"1996","unstructured":"Malec E, Malec T, Gagne MA, Dongier M (1996) Buspirone in the treatment of alcohol dependence: a placebo-controlled trial. Alcohol Clin Exp Res 20:307\u2013312","journal-title":"Alcohol Clin Exp Res"},{"key":"347_CR146","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s40122-021-00243-2","volume":"10","author":"L Manchikanti","year":"2021","unstructured":"Manchikanti L, Vanaparthy R, Atluri S, Sachdeva H, Kaye AD, Hirsch JA (2021) COVID-19 and the opioid epidemic: two public health emergencies that intersect with chronic pain. Pain Ther 10:269\u2013286","journal-title":"Pain Ther"},{"key":"347_CR147","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1038\/npp.2016.22","volume":"41","author":"A Manduca","year":"2016","unstructured":"Manduca A, Servadio M, Damsteegt R, Campolongo P, Vanderschuren LJ, Trezza V (2016) Dopaminergic neurotransmission in the nucleus accumbens modulates social play behavior in rats. Neuropsychopharmacology 41:2215\u20132223","journal-title":"Neuropsychopharmacology"},{"key":"347_CR148","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/ejn.14208","volume":"49","author":"RA Marino","year":"2019","unstructured":"Marino RA, Levy R (2019) Differential effects of D1 and D2 dopamine agonists on memory, motivation, learning and response time in non-human primates. Eur J Neurosci 49:199\u2013214","journal-title":"Eur J Neurosci"},{"key":"347_CR149","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.3389\/fphar.2020.01003","volume":"11","author":"JC Martel","year":"2020","unstructured":"Martel JC, Gatti McArthur S (2020) Dopamine receptor subtypes, physiology and pharmacology: new ligands and concepts in schizophrenia. Front Pharmacol 11:1003","journal-title":"Front Pharmacol"},{"key":"347_CR150","doi-asserted-by":"publisher","first-page":"17729","DOI":"10.1523\/JNEUROSCI.4570-11.2011","volume":"31","author":"A Matsui","year":"2011","unstructured":"Matsui A, Williams JT (2011) Opioid-sensitive GABA inputs from rostromedial tegmental nucleus synapse onto midbrain dopamine neurons. J Neurosci 31:17729\u201317735","journal-title":"J Neurosci"},{"key":"347_CR151","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/j.neuron.2014.04.030","volume":"82","author":"A Matsui","year":"2014","unstructured":"Matsui A, Jarvie BC, Robinson BG, Hentges ST, Williams JT (2014) Separate GABA afferents to dopamine neurons mediate acute action of opioids, development of tolerance, and expression of withdrawal. Neuron 82:1346\u20131356","journal-title":"Neuron"},{"key":"347_CR152","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.drugalcdep.2014.03.013","volume":"139","author":"D Matuskey","year":"2014","unstructured":"Matuskey D, Gallezot JD, Pittman B, Williams W, Wanyiri J, Gaiser E, Lee DE, Hannestad J, Lim K, Zheng MQ, Lin SF, Labaree D, Potenza MN, Carson RE, Malison RT, Ding YS (2014) Dopamine D(3) receptor alterations in cocaine-dependent humans imaged with [(1)(1)C](+)PHNO. Drug Alcohol Depend 139:100\u2013105","journal-title":"Drug Alcohol Depend"},{"key":"347_CR153","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/0006-8993(93)90084-Z","volume":"624","author":"A McGregor","year":"1993","unstructured":"McGregor A, Roberts DC (1993) Dopaminergic antagonism within the nucleus accumbens or the amygdala produces differential effects on intravenous cocaine self-administration under fixed and progressive ratio schedules of reinforcement. Brain Res 624:245\u2013252","journal-title":"Brain Res"},{"key":"347_CR154","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1080\/10550490490265325","volume":"13","author":"AL McRae","year":"2004","unstructured":"McRae AL, Sonne SC, Brady KT, Durkalski V, Palesch Y (2004) A randomized, placebo-controlled trial of buspirone for the treatment of anxiety in opioid-dependent individuals. Am J Addict 13:53\u201363","journal-title":"Am J Addict"},{"key":"347_CR155","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.drugalcdep.2015.08.013","volume":"156","author":"AL McRae-Clark","year":"2015","unstructured":"McRae-Clark AL, Baker NL, Gray KM, Killeen TK, Wagner AM, Brady KT, DeVane CL, Norton J (2015) Buspirone treatment of cannabis dependence: a randomized, placebo-controlled trial. Drug Alcohol Depend 156:29\u201337","journal-title":"Drug Alcohol Depend"},{"key":"347_CR156","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/0304-3940(92)90024-2","volume":"145","author":"JH Meador-Woodruff","year":"1992","unstructured":"Meador-Woodruff JH, Mansour A, Grandy DK, Damask SP, Civelli O, Watson SJ Jr (1992) Distribution of D5 dopamine receptor mRNA in rat brain. Neurosci Lett 145:209\u2013212","journal-title":"Neurosci Lett"},{"key":"347_CR157","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0166-4328(96)02270-X","volume":"87","author":"WM Meil","year":"1997","unstructured":"Meil WM, See RE (1997) Lesions of the basolateral amygdala abolish the ability of drug associated cues to reinstate responding during withdrawal from self-administered cocaine. Behav Brain Res 87:139\u2013148","journal-title":"Behav Brain Res"},{"key":"347_CR158","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1021\/jm901319p","volume":"53","author":"F Micheli","year":"2010","unstructured":"Micheli F, Arista L, Bonanomi G, Blaney FE, Braggio S, Capelli AM, Checchia A, Damiani F, Di-Fabio R, Fontana S, Gentile G, Griffante C, Hamprecht D, Marchioro C, Mugnaini M, Piner J, Ratti E, Tedesco G, Tarsi L, Terreni S, Worby A, Ashby CR Jr, Heidbreder C (2010) 1,2,4-Triazolyl azabicyclo[3.1.0]hexanes: a new series of potent and selective dopamine D(3) receptor antagonists. J Med Chem 53:374\u2013391","journal-title":"J Med Chem"},{"key":"347_CR159","first-page":"1048","volume":"293","author":"MJ Millan","year":"2000","unstructured":"Millan MJ, Gobert A, Newman-Tancredi A, Lejeune F, Cussac D, Rivet JM, Audinot V, Dubuffet T, Lavielle G (2000) S33084, a novel, potent, selective, and competitive antagonist at dopamine D(3)-receptors: I. Receptorial, electrophysiological and neurochemical profile compared with GR218,231 and L741,626. J Pharmacol Exp Ther 293:1048\u20131062","journal-title":"J Pharmacol Exp Ther"},{"key":"347_CR160","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1017\/S1461145710000775","volume":"13","author":"MJ Millan","year":"2010","unstructured":"Millan MJ, Buccafusco JJ, Loiseau F, Watson DJ, Decamp E, Fone KC, Thomasson-Perret N, Hill M, Mocaer E, Schneider JS (2010) The dopamine D3 receptor antagonist, S33138, counters cognitive impairment in a range of rodent and primate procedures. Int J Neuropsychopharmacol 13:1035\u20131051","journal-title":"Int J Neuropsychopharmacol"},{"key":"347_CR161","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1111\/bph.12357","volume":"170","author":"C Min","year":"2013","unstructured":"Min C, Zheng M, Zhang X, Caron MG, Kim KM (2013) Novel roles for beta-arrestins in the regulation of pharmacological sequestration to predict agonist-induced desensitization of dopamine D3 receptors. Br J Pharmacol 170:1112\u20131129","journal-title":"Br J Pharmacol"},{"key":"347_CR162","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1152\/physrev.1998.78.1.189","volume":"78","author":"C Missale","year":"1998","unstructured":"Missale C, Nash SR, Robinson SW, Jaber M, Caron MG (1998) Dopamine receptors: from structure to function. Physiol Rev 78:189\u2013225","journal-title":"Physiol Rev"},{"key":"347_CR163","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1097\/FBP.0b013e3283566a4a","volume":"23","author":"K Mogg","year":"2012","unstructured":"Mogg K, Bradley BP, O'Neill B, Bani M, Merlo-Pich E, Koch A, Bullmore ET, Nathan PJ (2012) Effect of dopamine D(3) receptor antagonism on approach responses to food cues in overweight and obese individuals. Behav Pharmacol 23:603\u2013608","journal-title":"Behav Pharmacol"},{"key":"347_CR164","doi-asserted-by":"publisher","first-page":"6723","DOI":"10.1073\/pnas.87.17.6723","volume":"87","author":"FJ Monsma Jr","year":"1990","unstructured":"Monsma FJ Jr, Mahan LC, McVittie LD, Gerfen CR, Sibley DR (1990) Molecular cloning and expression of a D1 dopamine receptor linked to adenylyl cyclase activation. Proc Natl Acad Sci U S A 87:6723\u20136727","journal-title":"Proc Natl Acad Sci U S A"},{"key":"347_CR165","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/npp.2012.171","volume":"38","author":"M Mugnaini","year":"2013","unstructured":"Mugnaini M, Iavarone L, Cavallini P, Griffante C, Oliosi B, Savoia C, Beaver J, Rabiner EA, Micheli F, Heidbreder C, Andorn A, Merlo Pich E, Bani M (2013) Occupancy of brain dopamine D3 receptors and drug craving: a translational approach. Neuropsychopharmacology 38:302\u2013312","journal-title":"Neuropsychopharmacology"},{"key":"347_CR166","doi-asserted-by":"publisher","first-page":"11271","DOI":"10.1073\/pnas.91.23.11271","volume":"91","author":"AM Murray","year":"1994","unstructured":"Murray AM, Ryoo HL, Gurevich E, Joyce JN (1994) Localization of dopamine D3 receptors to mesolimbic and D2 receptors to mesostriatal regions of human forebrain. Proc Natl Acad Sci U S A 91:11271\u201311275","journal-title":"Proc Natl Acad Sci U S A"},{"key":"347_CR167","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/YCO.0000000000000510","volume":"32","author":"P Murthy","year":"2019","unstructured":"Murthy P, Mahadevan J, Chand PK (2019) Treatment of substance use disorders with co-occurring severe mental health disorders. Curr Opin Psychiatry 32:293\u2013299","journal-title":"Curr Opin Psychiatry"},{"key":"347_CR168","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1001\/archpsyc.65.4.466","volume":"65","author":"H Myrick","year":"2008","unstructured":"Myrick H, Anton RF, Li X, Henderson S, Randall PK, Voronin K (2008) Effect of naltrexone and ondansetron on alcohol cue-induced activation of the ventral striatum in alcohol-dependent people. Arch Gen Psychiatry 65:466\u2013475","journal-title":"Arch Gen Psychiatry"},{"key":"347_CR169","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.euroneuro.2013.05.006","volume":"23","author":"S Nakajima","year":"2013","unstructured":"Nakajima S, Gerretsen P, Takeuchi H, Caravaggio F, Chow T, Le Foll B, Mulsant B, Pollock B, Graff-Guerrero A (2013) The potential role of dopamine D(3) receptor neurotransmission in cognition. Eur Neuropsychopharmacol 23:799\u2013813","journal-title":"Eur Neuropsychopharmacol"},{"key":"347_CR170","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.bbr.2013.04.012","volume":"249","author":"T Nakako","year":"2013","unstructured":"Nakako T, Murai T, Ikejiri M, Ishiyama T, Taiji M, Ikeda K (2013) Effects of a dopamine D1 agonist on ketamine-induced spatial working memory dysfunction in common marmosets. Behav Brain Res 249:109\u2013115","journal-title":"Behav Brain Res"},{"key":"347_CR171","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.tins.2008.09.009","volume":"32","author":"NH Naqvi","year":"2009","unstructured":"Naqvi NH, Bechara A (2009) The hidden island of addiction: the insula. Trends Neurosci 32:56\u201367","journal-title":"Trends Neurosci"},{"key":"347_CR172","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1126\/science.1135926","volume":"315","author":"NH Naqvi","year":"2007","unstructured":"Naqvi NH, Rudrauf D, Damasio H, Bechara A (2007) Damage to the insula disrupts addiction to cigarette smoking. Science 315:531\u2013534","journal-title":"Science"},{"key":"347_CR173","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1080\/08897077.2021.1900981","volume":"42","author":"A Narayan","year":"2021","unstructured":"Narayan A, Balkrishnan R (2021) A health crisis within a health crisis: opioid access in the COVID-19 pandemic. Subst Abus 42:148\u2013152","journal-title":"Subst Abus"},{"key":"347_CR174","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/syn.20325","volume":"60","author":"R Narendran","year":"2006","unstructured":"Narendran R, Slifstein M, Guillin O, Hwang Y, Hwang DR, Scher E, Reeder S, Rabiner E, Laruelle M (2006) Dopamine (D2\/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo. Synapse 60:485\u2013495","journal-title":"Synapse"},{"key":"347_CR175","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/syn.20633","volume":"63","author":"R Narendran","year":"2009","unstructured":"Narendran R, Frankle WG, Mason NS, Laymon CM, Lopresti BJ, Price JC, Kendro S, Vora S, Litschge M, Mountz JM, Mathis CA (2009) Positron emission tomography imaging of D(2\/3) agonist binding in healthy human subjects with the radiotracer [(11)C]-N-propyl-norapomorphine: preliminary evaluation and reproducibility studies. Synapse 63:574\u2013584","journal-title":"Synapse"},{"key":"347_CR176","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1017\/S1461145711001052","volume":"15","author":"PJ Nathan","year":"2012","unstructured":"Nathan PJ, O'Neill BV, Mogg K, Bradley BP, Beaver J, Bani M, Merlo-Pich E, Fletcher PC, Swirski B, Koch A, Dodds CM, Bullmore ET (2012) The effects of the dopamine D(3) receptor antagonist GSK598809 on attentional bias to palatable food cues in overweight and obese subjects. Int J Neuropsychopharmacol 15:149\u2013161","journal-title":"Int J Neuropsychopharmacol"},{"key":"347_CR177","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1523\/JNEUROSCI.20-02-00798.2000","volume":"20","author":"JL Neisewander","year":"2000","unstructured":"Neisewander JL, Baker DA, Fuchs RA, Tran-Nguyen LT, Palmer A, Marshall JF (2000) Fos protein expression and cocaine-seeking behavior in rats after exposure to a cocaine self-administration environment. J Neurosci 20:798\u2013805","journal-title":"J Neurosci"},{"key":"347_CR178","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.bcp.2012.06.023","volume":"84","author":"AH Newman","year":"2012","unstructured":"Newman AH, Blaylock BL, Nader MA, Bergman J, Sibley DR, Skolnick P (2012) Medication discovery for addiction: translating the dopamine D3 receptor hypothesis. Biochem Pharmacol 84:882\u2013890","journal-title":"Biochem Pharmacol"},{"key":"347_CR179","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1146\/annurev-pharmtox-030220-124205","volume":"61","author":"AH Newman","year":"2021","unstructured":"Newman AH, Ku T, Jordan CJ, Bonifazi A, Xi ZX (2021) New drugs, old targets: tweaking the dopamine system to treat psychostimulant use disorders. Annu Rev Pharmacol Toxicol 61:609\u2013628","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"347_CR180","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/S0893-133X(98)00083-9","volume":"20","author":"LE O'Dell","year":"1999","unstructured":"O'Dell LE, Sussman AN, Meyer KL, Neisewander JL (1999) Behavioral effects of psychomotor stimulant infusions into amygdaloid nuclei. Neuropsychopharmacology 20:591\u2013602","journal-title":"Neuropsychopharmacology"},{"key":"347_CR181","first-page":"137","volume":"4","author":"KL O'Malley","year":"1992","unstructured":"O'Malley KL, Harmon S, Tang L, Todd RD (1992) The rat dopamine D4 receptor: sequence, gene structure, and demonstration of expression in the cardiovascular system. New Biol 4:137\u2013146","journal-title":"New Biol"},{"key":"347_CR182","unstructured":"Opioid-Use-Disorder (2020) Opioid use disorder: endpoints for demonstrating effectiveness of drugs for treatment guidance for industry. https:\/\/www.fda.gov\/media\/114948\/download.accessed"},{"key":"347_CR183","doi-asserted-by":"publisher","first-page":"119","DOI":"10.17305\/bjbms.2013.2394","volume":"13","author":"E Ozdemir","year":"2013","unstructured":"Ozdemir E, Bagcivan I, Gursoy S (2013) Role of D(1)\/D(2) dopamin receptors antagonist perphenazine in morphine analgesia and tolerance in rats. Bosn J Basic Med Sci 13:119\u2013125","journal-title":"Bosn J Basic Med Sci"},{"key":"347_CR184","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/BF02246582","volume":"123","author":"G Panagis","year":"1996","unstructured":"Panagis G, Spyraki C (1996) Neuropharmacological evidence for the role of dopamine in ventral pallidum self-stimulation. Psychopharmacology 123:280\u2013288","journal-title":"Psychopharmacology"},{"key":"347_CR185","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.biopsych.2008.08.028","volume":"65","author":"F Patterson","year":"2009","unstructured":"Patterson F, Jepson C, Strasser AA, Loughead J, Perkins KA, Gur RC, Frey JM, Siegel S, Lerman C (2009) Varenicline improves mood and cognition during smoking abstinence. Biol Psychiatry 65:144\u2013149","journal-title":"Biol Psychiatry"},{"key":"347_CR186","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/j.euroneuro.2015.07.012","volume":"25","author":"EM Pich","year":"2015","unstructured":"Pich EM, Collo G (2015) Pharmacological targeting of dopamine D3 receptors: possible clinical applications of selective drugs. Eur Neuropsychopharmacol 25:1437\u20131447","journal-title":"Eur Neuropsychopharmacol"},{"key":"347_CR187","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1192\/bjp.bp.112.116855","volume":"202","author":"RM Post","year":"2013","unstructured":"Post RM, Kalivas P (2013) Bipolar disorder and substance misuse: pathological and therapeutic implications of their comorbidity and cross-sensitisation. Br J Psychiatry 202:172\u2013176","journal-title":"Br J Psychiatry"},{"key":"347_CR188","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1016\/j.neuron.2021.05.002","volume":"109","author":"H Pribiag","year":"2021","unstructured":"Pribiag H, Shin S, Wang EH, Sun F, Datta P, Okamoto A, Guss H, Jain A, Wang XY, De Freitas B, Honma P, Pate S, Lilascharoen V, Li Y, Lim BK (2021) Ventral pallidum DRD3 potentiates a pallido-habenular circuit driving accumbal dopamine release and cocaine seeking. Neuron 109:2165\u20132182.e2110","journal-title":"Neuron"},{"key":"347_CR189","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1152\/jn.00516.2010","volume":"105","author":"GA Prieto","year":"2011","unstructured":"Prieto GA, Perez-Burgos A, Palomero-Rivero M, Galarraga E, Drucker-Colin R, Bargas J (2011) Upregulation of D2-class signaling in dopamine-denervated striatum is in part mediated by D3 receptors acting on ca V 2.1 channels via PIP2 depletion. J Neurophysiol 105:2260\u20132274","journal-title":"J Neurophysiol"},{"key":"347_CR190","doi-asserted-by":"publisher","first-page":"725","DOI":"10.7326\/0003-4819-149-10-200811180-00007","volume":"149","author":"A Qaseem","year":"2008","unstructured":"Qaseem A, Snow V, Denberg TD, Forciea MA, Owens DK, Clinical Efficacy Assessment Subcommittee of American College of Physicians (2008) Using second-generation antidepressants to treat depressive disorders: a clinical practice guideline from the American College of Physicians. Ann Intern Med 149:725\u2013733","journal-title":"Ann Intern Med"},{"key":"347_CR191","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1017\/S1461145710000088","volume":"13","author":"EA Rabiner","year":"2010","unstructured":"Rabiner EA, Laruelle M (2010) Imaging the D3 receptor in humans in vivo using [11C](+)-PHNO positron emission tomography (PET). Int J Neuropsychopharmacol 13:289\u2013290","journal-title":"Int J Neuropsychopharmacol"},{"key":"347_CR192","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1002\/syn.20658","volume":"63","author":"EA Rabiner","year":"2009","unstructured":"Rabiner EA, Slifstein M, Nobrega J, Plisson C, Huiban M, Raymond R, Diwan M, Wilson AA, McCormick P, Gentile G, Gunn RN, Laruelle MA (2009) In vivo quantification of regional dopamine-D3 receptor binding potential of (+)-PHNO: studies in non-human primates and transgenic mice. Synapse 63:782\u2013793","journal-title":"Synapse"},{"key":"347_CR193","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/j.1521-0391.2013.12065.x","volume":"23","author":"WN Raby","year":"2014","unstructured":"Raby WN, Rubin EA, Garawi F, Cheng W, Mason E, Sanfilippo L, Lord S, Bisaga A, Aharonovich E, Levin F, McDowell D, Nunes EV (2014) A randomized, double-blind, placebo-controlled trial of venlafaxine for the treatment of depressed cocaine-dependent patients. Am J Addict 23:68\u201375","journal-title":"Am J Addict"},{"key":"347_CR194","doi-asserted-by":"publisher","first-page":"e13028","DOI":"10.1111\/adb.13028","volume":"26","author":"PS Regier","year":"2021","unstructured":"Regier PS, Jagannathan K, Franklin TR, Wetherill RR, Langleben DD, Gawyrsiak M, Kampman KM, Childress AR (2021) Sustained brain response to repeated drug cues is associated with poor drug-use outcomes. Addict Biol 26:e13028","journal-title":"Addict Biol"},{"issue":"1","key":"347_CR195","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1080\/10550887.2021.1945398","volume":"40","author":"V Ricci","year":"2022","unstructured":"Ricci V, Di Salvo G, Maina G (2022) Remission of persistent methamphetamine-induced psychosis after cariprazine therapy: presentation of a case report. J Addict Dis 40(1):145\u2013148","journal-title":"J Addict Dis"},{"key":"347_CR196","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/syn.20983","volume":"66","author":"OV Rice","year":"2012","unstructured":"Rice OV, Gardner EL, Heidbreder CA, Ashby CR Jr (2012) The acute administration of the selective dopamine D(3) receptor antagonist SB-277011A reverses conditioned place aversion produced by naloxone precipitated withdrawal from acute morphine administration in rats. Synapse 66:85\u201387","journal-title":"Synapse"},{"key":"347_CR197","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1038\/sj.npp.1301163","volume":"31","author":"NM Richtand","year":"2006","unstructured":"Richtand NM (2006) Behavioral sensitization, alternative splicing, and d3 dopamine receptor-mediated inhibitory function. Neuropsychopharmacology 31:2368\u20132375","journal-title":"Neuropsychopharmacology"},{"key":"347_CR198","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.neuroscience.2019.03.034","volume":"406","author":"HM Rodgers","year":"2019","unstructured":"Rodgers HM, Yow J, Evans E, Clemens S, Brewer KL (2019) Dopamine D1 and D3 receptor modulators restore morphine analgesia and prevent opioid preference in a model of neuropathic pain. Neuroscience 406:376\u2013388","journal-title":"Neuroscience"},{"key":"347_CR199","doi-asserted-by":"publisher","first-page":"172935","DOI":"10.1016\/j.pbb.2020.172935","volume":"194","author":"HM Rodgers","year":"2020","unstructured":"Rodgers HM, Lim SA, Yow J, Dinkins ML, Patton R, Clemens S, Brewer KL (2020) Dopamine D1 or D3 receptor modulators prevent morphine tolerance and reduce opioid withdrawal symptoms. Pharmacol Biochem Behav 194:172935","journal-title":"Pharmacol Biochem Behav"},{"key":"347_CR200","doi-asserted-by":"publisher","first-page":"101978","DOI":"10.1016\/j.cpr.2021.101978","volume":"84","author":"AH Rogers","year":"2021","unstructured":"Rogers AH, Zvolensky MJ, Ditre JW, Buckner JD, Asmundson GJG (2021) Association of opioid misuse with anxiety and depression: a systematic review of the literature. Clin Psychol Rev 84:101978","journal-title":"Clin Psychol Rev"},{"key":"347_CR201","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s00213-012-2906-7","volume":"226","author":"V Roman","year":"2013","unstructured":"Roman V, Gyertyan I, Saghy K, Kiss B, Szombathelyi Z (2013) Cariprazine (RGH-188), a D(3)-preferring dopamine D(3)\/D(2) receptor partial agonist antipsychotic candidate demonstrates anti-abuse potential in rats. Psychopharmacology 226:285\u2013293","journal-title":"Psychopharmacology"},{"key":"347_CR202","doi-asserted-by":"publisher","first-page":"re14","DOI":"10.1126\/stke.3092005re14","volume":"2005","author":"D Ron","year":"2005","unstructured":"Ron D, Jurd R (2005) The \u201cups and downs\u201d of signaling cascades in addiction. Sci STKE 2005:re14","journal-title":"Sci STKE"},{"key":"347_CR203","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.1521-0391.2003.tb00653.x","volume":"12","author":"JS Rose","year":"2003","unstructured":"Rose JS, Branchey M, Wallach L, Buydens-Branchey L (2003) Effects of buspirone in withdrawal from opiates. Am J Addict 12:253\u2013259","journal-title":"Am J Addict"},{"key":"347_CR204","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.1471-4159.1991.tb02557.x","volume":"56","author":"SB Ross","year":"1991","unstructured":"Ross SB (1991) Synaptic concentration of dopamine in the mouse striatum in relationship to the kinetic properties of the dopamine receptors and uptake mechanism. J Neurochem 56:22\u201329","journal-title":"J Neurochem"},{"key":"347_CR205","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/ijnp\/pyaa096","volume":"24","author":"A Salin","year":"2021","unstructured":"Salin A, Lardeux V, Solinas M, Belujon P (2021) Protracted abstinence from extended cocaine self-administration is associated with hypodopaminergic activity in the VTA but not in the SNc. Int J Neuropsychopharmacol 24:499\u2013504","journal-title":"Int J Neuropsychopharmacol"},{"key":"347_CR206","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1080\/00952990.2017.1292279","volume":"43","author":"IM Salloum","year":"2017","unstructured":"Salloum IM, Brown ES (2017) Management of comorbid bipolar disorder and substance use disorders. Am J Drug Alcohol Abuse 43:366\u2013376","journal-title":"Am J Drug Alcohol Abuse"},{"key":"347_CR207","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.tins.2021.03.003","volume":"44","author":"AN Samaha","year":"2021","unstructured":"Samaha AN, Khoo SY, Ferrario CR, Robinson TE (2021) Dopamine \u2018ups and downs\u2019 in addiction revisited. Trends Neurosci 44:516\u2013526","journal-title":"Trends Neurosci"},{"key":"347_CR208","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.coph.2020.11.001","volume":"56","author":"A Sanna","year":"2021","unstructured":"Sanna A, Fattore L, Badas P, Corona G, Diana M (2021) The hypodopaminergic state ten years after: transcranial magnetic stimulation as a tool to test the dopamine hypothesis of drug addiction. Curr Opin Pharmacol 56:61\u201367","journal-title":"Curr Opin Pharmacol"},{"key":"347_CR209","doi-asserted-by":"publisher","first-page":"6773","DOI":"10.1523\/JNEUROSCI.22-15-06773.2002","volume":"22","author":"BL Schmidt","year":"2002","unstructured":"Schmidt BL, Tambeli CH, Barletta J, Luo L, Green P, Levine JD, Gear RW (2002) Altered nucleus accumbens circuitry mediates pain-induced antinociception in morphine-tolerant rats. J Neurosci 22:6773\u20136780","journal-title":"J Neurosci"},{"key":"347_CR210","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/S0009-9236(96)90153-8","volume":"60","author":"NG Schneider","year":"1996","unstructured":"Schneider NG, Olmstead RE, Steinberg C, Sloan K, Daims RM, Brown HV (1996) Efficacy of buspirone in smoking cessation: a placebo-controlled trial. Clin Pharmacol Ther 60:568\u2013575","journal-title":"Clin Pharmacol Ther"},{"key":"347_CR211","doi-asserted-by":"publisher","first-page":"e12744","DOI":"10.1111\/adb.12744","volume":"25","author":"G Scuppa","year":"2020","unstructured":"Scuppa G, Tambalo S, Pfarr S, Sommer WH, Bifone A (2020) Aberrant insular cortex connectivity in abstinent alcohol-dependent rats is reversed by dopamine D3 receptor blockade. Addict Biol 25:e12744","journal-title":"Addict Biol"},{"key":"347_CR212","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.biopsych.2010.04.038","volume":"68","author":"G Searle","year":"2010","unstructured":"Searle G, Beaver JD, Comley RA, Bani M, Tziortzi A, Slifstein M, Mugnaini M, Griffante C, Wilson AA, Merlo-Pich E, Houle S, Gunn R, Rabiner EA, Laruelle M (2010) Imaging dopamine D3 receptors in the human brain with positron emission tomography, [11C]PHNO, and a selective D3 receptor antagonist. Biol Psychiatry 68:392\u2013399","journal-title":"Biol Psychiatry"},{"key":"347_CR213","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/syn.20193","volume":"58","author":"P Seeman","year":"2005","unstructured":"Seeman P, Ko F, Willeit M, McCormick P, Ginovart N (2005) Antiparkinson concentrations of pramipexole and PHNO occupy dopamine D2(high) and D3(high) receptors. Synapse 58:122\u2013128","journal-title":"Synapse"},{"key":"347_CR214","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S0169-328X(97)00025-9","volume":"45","author":"DM Segal","year":"1997","unstructured":"Segal DM, Moraes CT, Mash DC (1997) Up-regulation of D3 dopamine receptor mRNA in the nucleus accumbens of human cocaine fatalities. Brain Res Mol Brain Res 45:335\u2013339","journal-title":"Brain Res Mol Brain Res"},{"key":"347_CR215","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/nn.3445","volume":"16","author":"T Seif","year":"2013","unstructured":"Seif T, Chang SJ, Simms JA, Gibb SL, Dadgar J, Chen BT, Harvey BK, Ron D, Messing RO, Bonci A, Hopf FW (2013) Cortical activation of accumbens hyperpolarization-active NMDARs mediates aversion-resistant alcohol intake. Nat Neurosci 16:1094\u20131100","journal-title":"Nat Neurosci"},{"key":"347_CR216","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1146\/annurev.ne.18.030195.002335","volume":"18","author":"DW Self","year":"1995","unstructured":"Self DW, Nestler EJ (1995) Molecular mechanisms of drug reinforcement and addiction. Annu Rev Neurosci 18:463\u2013495","journal-title":"Annu Rev Neurosci"},{"key":"347_CR217","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1093\/brain\/awu305","volume":"138","author":"VV Senatorov","year":"2015","unstructured":"Senatorov VV, Damadzic R, Mann CL, Schwandt ML, George DT, Hommer DW, Heilig M, Momenan R (2015) Reduced anterior insula, enlarged amygdala in alcoholism and associated depleted von Economo neurons. Brain 138:69\u201379","journal-title":"Brain"},{"key":"347_CR218","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s002130050479","volume":"135","author":"RA Shafer","year":"1998","unstructured":"Shafer RA, Levant B (1998) The D3 dopamine receptor in cellular and organismal function. Psychopharmacology 135:1\u201316","journal-title":"Psychopharmacology"},{"key":"347_CR219","doi-asserted-by":"publisher","first-page":"9061","DOI":"10.1021\/acs.jmedchem.9b00607","volume":"62","author":"AB Shaik","year":"2019","unstructured":"Shaik AB, Kumar V, Bonifazi A, Guerrero AM, Cemaj SL, Gadiano A, Lam J, Xi ZX, Rais R, Slusher BS, Newman AH (2019) Investigation of novel primary and secondary pharmacophores and 3-substitution in the linking chain of a series of highly selective and bitopic dopamine D3 receptor antagonists and partial agonists. J Med Chem 62:9061\u20139077","journal-title":"J Med Chem"},{"key":"347_CR220","doi-asserted-by":"publisher","first-page":"173104","DOI":"10.1016\/j.pbb.2021.173104","volume":"202","author":"H Shen","year":"2021","unstructured":"Shen H, Chen K, Marino RAM, McDevitt RA, Xi ZX (2021) Deletion of VGLUT2 in midbrain dopamine neurons attenuates dopamine and glutamate responses to methamphetamine in mice. Pharmacol Biochem Behav 202:173104","journal-title":"Pharmacol Biochem Behav"},{"key":"347_CR221","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.conb.2013.01.026","volume":"23","author":"RJ Smith","year":"2013","unstructured":"Smith RJ, Lobo MK, Spencer S, Kalivas PW (2013) Cocaine-induced adaptations in D1 and D2 accumbens projection neurons (a dichotomy not necessarily synonymous with direct and indirect pathways). Curr Opin Neurobiol 23:546\u2013552","journal-title":"Curr Opin Neurobiol"},{"key":"347_CR222","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.bbr.2015.04.025","volume":"289","author":"LN Smith","year":"2015","unstructured":"Smith LN, Bachus SE, McDonald CG, Smith RF (2015) Role of the D3 dopamine receptor in nicotine sensitization. Behav Brain Res 289:92\u2013104","journal-title":"Behav Brain Res"},{"key":"347_CR223","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/347146a0","volume":"347","author":"P Sokoloff","year":"1990","unstructured":"Sokoloff P, Giros B, Martres MP, Bouthenet ML, Schwartz JC (1990) Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 347:146\u2013151","journal-title":"Nature"},{"key":"347_CR224","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0304-3940(97)13396-1","volume":"223","author":"GD Stanwood","year":"1997","unstructured":"Stanwood GD, McElligot S, Lu L, McGonigle P (1997) Ontogeny of dopamine D3 receptors in the nucleus accumbens of the rat. Neurosci Lett 223:13\u201316","journal-title":"Neurosci Lett"},{"key":"347_CR225","first-page":"1223","volume":"295","author":"GD Stanwood","year":"2000","unstructured":"Stanwood GD, Artymyshyn RP, Kung MP, Kung HF, Lucki I, McGonigle P (2000) Quantitative autoradiographic mapping of rat brain dopamine D3 binding with [(125)I]7-OH-PIPAT: evidence for the presence of D3 receptors on dopaminergic and nondopaminergic cell bodies and terminals. J Pharmacol Exp Ther 295:1223\u20131231","journal-title":"J Pharmacol Exp Ther"},{"key":"347_CR226","unstructured":"Statement-from-FDA-Commissioner (2018) Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to encourage more widespread innovation and development of new treatments for opioid use disorder. https:\/\/www.fda.gov\/news-events\/press-announcements\/statement-fda-commissioner-scott-gottlieb-md-new-steps-encourage-more-widespread-innovation-and.accessed"},{"key":"347_CR227","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1001\/jamapsychiatry.2021.0259","volume":"78","author":"EC Strain","year":"2021","unstructured":"Strain EC, Kampman KM, Weiss RD (2021) Moving beyond medications that act at the mu receptor in the treatment of opioid use disorder. JAMA Psychiat 78:701\u2013702","journal-title":"JAMA Psychiat"},{"key":"347_CR228","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.biopsych.2013.02.026","volume":"74","author":"EV Sullivan","year":"2013","unstructured":"Sullivan EV, Muller-Oehring E, Pitel AL, Chanraud S, Shankaranarayanan A, Alsop DC, Rohlfing T, Pfefferbaum A (2013) A selective insular perfusion deficit contributes to compromised salience network connectivity in recovering alcoholic men. Biol Psychiatry 74:547\u2013555","journal-title":"Biol Psychiatry"},{"key":"347_CR229","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/S0006-8993(97)01078-0","volume":"779","author":"M Suzuki","year":"1998","unstructured":"Suzuki M, Hurd YL, Sokoloff P, Schwartz JC, Sedvall G (1998) D3 dopamine receptor mRNA is widely expressed in the human brain. Brain Res 779:58\u201374","journal-title":"Brain Res"},{"key":"347_CR230","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ejphar.2007.10.011","volume":"579","author":"SN Swain","year":"2008","unstructured":"Swain SN, Beuk J, Heidbreder CA, Beninger RJ (2008) Role of dopamine D3 receptors in the expression of conditioned fear in rats. Eur J Pharmacol 579:167\u2013176","journal-title":"Eur J Pharmacol"},{"key":"347_CR231","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.coph.2020.07.007","volume":"56","author":"G Tanda","year":"2021","unstructured":"Tanda G, Hersey M, Hempel B, Xi ZX, Newman AH (2021) Modafinil and its structural analogs as atypical dopamine uptake inhibitors and potential medications for psychostimulant use disorder. Curr Opin Pharmacol 56:13\u201321","journal-title":"Curr Opin Pharmacol"},{"issue":"10312","key":"347_CR232","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/S0140-6736(21)02221-2","volume":"398","author":"M Taquet","year":"2021","unstructured":"Taquet M, Holmes EA, Harrison PJ (2021a) Depression and anxiety disorders during the COVID-19 pandemic: knowns and unknowns. Lancet 398(10312):1665\u20131666","journal-title":"Lancet"},{"key":"347_CR233","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/S2215-0366(20)30462-4","volume":"8","author":"M Taquet","year":"2021","unstructured":"Taquet M, Luciano S, Geddes JR, Harrison PJ (2021b) Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psychiatry 8:130\u2013140","journal-title":"Lancet Psychiatry"},{"issue":"Suppl 1","key":"347_CR234","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/0091-3057(82)90507-X","volume":"17","author":"DP Taylor","year":"1982","unstructured":"Taylor DP, Riblet LA, Stanton HC, Eison AS, Eison MS, Temple DL Jr (1982) Dopamine and antianxiety activity. Pharmacol Biochem Behav 17(Suppl 1):25\u201335","journal-title":"Pharmacol Biochem Behav"},{"key":"347_CR235","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1124\/jpet.117.241141","volume":"362","author":"M Thomsen","year":"2017","unstructured":"Thomsen M, Barrett AC, Butler P, Negus SS, Caine SB (2017) Effects of acute and chronic treatments with dopamine D2 and D3 receptor ligands on cocaine versus food choice in rats. J Pharmacol Exp Ther 362:161\u2013176","journal-title":"J Pharmacol Exp Ther"},{"key":"347_CR236","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1056\/NEJMoa2020214","volume":"384","author":"MH Trivedi","year":"2021","unstructured":"Trivedi MH, Walker R, Ling W, Dela Cruz A, Sharma G, Carmody T, Ghitza UE, Wahle A, Kim M, Shores-Wilson K, Sparenborg S, Coffin P, Schmitz J, Wiest K, Bart G, Sonne SC, Wakhlu S, Rush AJ, Nunes EV, Shoptaw S (2021) Bupropion and naltrexone in methamphetamine use disorder. N Engl J Med 384:140\u2013153","journal-title":"N Engl J Med"},{"key":"347_CR237","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jsat.2019.10.005","volume":"109","author":"JI Tsui","year":"2020","unstructured":"Tsui JI, Mayfield J, Speaker EC, Yakup S, Ries R, Funai H, Leroux BG, Merrill JO (2020) Association between methamphetamine use and retention among patients with opioid use disorders treated with buprenorphine. J Subst Abus Treat 109:80\u201385","journal-title":"J Subst Abus Treat"},{"key":"347_CR238","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/sj.mp.4000859","volume":"6","author":"E Tupala","year":"2001","unstructured":"Tupala E, Hall H, Bergstrom K, Sarkioja T, Rasanen P, Mantere T, Callaway J, Hiltunen J, Tiihonen J (2001) Dopamine D(2)\/D(3)-receptor and transporter densities in nucleus accumbens and amygdala of type 1 and 2 alcoholics. Mol Psychiatry 6:261\u2013267","journal-title":"Mol Psychiatry"},{"key":"347_CR239","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.biopsych.2004.07.007","volume":"56","author":"ND Volkow","year":"2004","unstructured":"Volkow ND (2004) The reality of comorbidity: depression and drug abuse. Biol Psychiatry 56:714\u2013717","journal-title":"Biol Psychiatry"},{"key":"347_CR240","doi-asserted-by":"crossref","unstructured":"Volkow ND (2021) Drug overdose deaths in 2020 were horrifying. Radical change is needed to address the drug crisis. Scientific America. https:\/\/www.drugabuse.gov\/about-nida\/noras-blog\/2021\/2008\/drug-overdose-deaths-in-2020-were-horrifying-radical-change-needed-to-address-drug-crisis","DOI":"10.1038\/scientificamerican122021-5r9QLu8N6gaBNENzzG1nC7"},{"key":"347_CR241","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1358\/dot.2018.54.4.2812620","volume":"54","author":"G Walker","year":"2018","unstructured":"Walker G (2018) The opioid crisis: a 21st century pain. Drugs Today (Barc) 54:283\u2013286","journal-title":"Drugs Today (Barc)"},{"key":"347_CR242","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.bcp.2009.10.016","volume":"79","author":"L Westrich","year":"2010","unstructured":"Westrich L, Gil-Mast S, Kortagere S, Kuzhikandathil EV (2010) Development of tolerance in D3 dopamine receptor signaling is accompanied by distinct changes in receptor conformation. Biochem Pharmacol 79:897\u2013907","journal-title":"Biochem Pharmacol"},{"key":"347_CR243","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.drugalcdep.2005.08.010","volume":"81","author":"A Williamson","year":"2006","unstructured":"Williamson A, Darke S, Ross J, Teesson M (2006) The effect of persistence of cocaine use on 12-month outcomes for the treatment of heroin dependence. Drug Alcohol Depend 81:293\u2013300","journal-title":"Drug Alcohol Depend"},{"key":"347_CR244","doi-asserted-by":"publisher","first-page":"757","DOI":"10.4088\/JCP.13m08862","volume":"75","author":"TM Winhusen","year":"2014","unstructured":"Winhusen TM, Kropp F, Lindblad R, Douaihy A, Haynes L, Hodgkins C, Chartier K, Kampman KM, Sharma G, Lewis DF, VanVeldhuisen P, Theobald J, May J, Brigham GS (2014) Multisite, randomized, double-blind, placebo-controlled pilot clinical trial to evaluate the efficacy of buspirone as a relapse-prevention treatment for cocaine dependence. J Clin Psychiatry 75:757\u2013764","journal-title":"J Clin Psychiatry"},{"key":"347_CR245","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1146\/annurev.ne.19.030196.001535","volume":"19","author":"RA Wise","year":"1996","unstructured":"Wise RA (1996) Addictive drugs and brain stimulation reward. Annu Rev Neurosci 19:319\u2013340","journal-title":"Annu Rev Neurosci"},{"key":"347_CR246","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/cne.20689","volume":"493","author":"RA Wise","year":"2005","unstructured":"Wise RA (2005) Forebrain substrates of reward and motivation. J Comp Neurol 493:115\u2013121","journal-title":"J Comp Neurol"},{"key":"347_CR247","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1176\/appi.ajp.2008.07121877","volume":"165","author":"J Wrase","year":"2008","unstructured":"Wrase J, Makris N, Braus DF, Mann K, Smolka MN, Kennedy DN, Caviness VS, Hodge SM, Tang L, Albaugh M, Ziegler DA, Davis OC, Kissling C, Schumann G, Breiter HC, Heinz A (2008) Amygdala volume associated with alcohol abuse relapse and craving. Am J Psychiatry 165:1179\u20131184","journal-title":"Am J Psychiatry"},{"key":"347_CR248","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1093\/alcalc\/37.5.485","volume":"37","author":"ZX Xi","year":"2002","unstructured":"Xi ZX, Stein EA (2002) GABAergic mechanisms of opiate reinforcement. Alcohol Alcohol 37:485\u2013494","journal-title":"Alcohol Alcohol"},{"key":"347_CR249","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1111\/j.1369-1600.2012.00486.x","volume":"18","author":"ZX Xi","year":"2013","unstructured":"Xi ZX, Li X, Li J, Peng XQ, Song R, Gaal J, Gardner EL (2013) Blockade of dopamine D3 receptors in the nucleus accumbens and central amygdala inhibits incubation of cocaine craving in rats. Addict Biol 18:665\u2013677","journal-title":"Addict Biol"},{"key":"347_CR250","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.phrs.2019.03.003","volume":"143","author":"W Xu","year":"2019","unstructured":"Xu W, Reith MEA, Liu-Chen LY, Kortagere S (2019) Biased signaling agonist of dopamine D3 receptor induces receptor internalization independent of beta-arrestin recruitment. Pharmacol Res 143:48\u201357","journal-title":"Pharmacol Res"},{"key":"347_CR251","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1089\/ars.2020.8106","volume":"34","author":"J Yang","year":"2021","unstructured":"Yang J, Villar VAM, Jose PA, Zeng C (2021) Renal dopamine receptors and oxidative stress: role in hypertension. Antioxid Redox Signal 34:716\u2013735","journal-title":"Antioxid Redox Signal"},{"key":"347_CR252","doi-asserted-by":"publisher","first-page":"12764","DOI":"10.1073\/pnas.1210797109","volume":"109","author":"S Yawata","year":"2012","unstructured":"Yawata S, Yamaguchi T, Danjo T, Hikida T, Nakanishi S (2012) Pathway-specific control of reward learning and its flexibility via selective dopamine receptors in the nucleus accumbens. Proc Natl Acad Sci U S A 109:12764\u201312769","journal-title":"Proc Natl Acad Sci U S A"},{"key":"347_CR253","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.neuropharm.2017.09.007","volume":"126","author":"ZB You","year":"2017","unstructured":"You ZB, Gao JT, Bi GH, He Y, Boateng C, Cao J, Gardner EL, Newman AH, Xi ZX (2017) The novel dopamine D3 receptor antagonists\/partial agonists CAB2-015 and BAK4-54 inhibit oxycodone-taking and oxycodone-seeking behavior in rats. Neuropharmacology 126:190\u2013199","journal-title":"Neuropharmacology"},{"key":"347_CR254","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/s41386-018-0284-5","volume":"44","author":"ZB You","year":"2019","unstructured":"You ZB, Bi GH, Galaj E, Kumar V, Cao J, Gadiano A, Rais R, Slusher BS, Gardner EL, Xi ZX, Newman AH (2019) Dopamine D3R antagonist VK4-116 attenuates oxycodone self-administration and reinstatement without compromising its antinociceptive effects. Neuropsychopharmacology 44:1415\u20131424","journal-title":"Neuropsychopharmacology"},{"key":"347_CR255","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S0306-4522(03)00531-1","volume":"121","author":"IA Yun","year":"2003","unstructured":"Yun IA, Fields HL (2003) Basolateral amygdala lesions impair both cue- and cocaine-induced reinstatement in animals trained on a discriminative stimulus task. Neuroscience 121:747\u2013757","journal-title":"Neuroscience"},{"key":"347_CR256","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1093\/ntr\/ntu227","volume":"17","author":"EL Zale","year":"2015","unstructured":"Zale EL, Dorfman ML, Hooten WM, Warner DO, Zvolensky MJ, Ditre JW (2015) Tobacco smoking, nicotine dependence, and patterns of prescription opioid misuse: results from a nationally representative sample. Nicotine Tob Res 17:1096\u20131103","journal-title":"Nicotine Tob Res"},{"key":"347_CR257","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1177\/026988110201600312","volume":"16","author":"MR Zarrindast","year":"2002","unstructured":"Zarrindast MR, Dinkoub Z, Homayoun H, Bakhtiarian A, Khavandgar S (2002) Dopamine receptor mechanism(s) and morphine tolerance in mice. J Psychopharmacol 16:261\u2013266","journal-title":"J Psychopharmacol"},{"key":"347_CR258","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1152\/physiolgenomics.00127.2004","volume":"19","author":"C Zeng","year":"2004","unstructured":"Zeng C, Sanada H, Watanabe H, Eisner GM, Felder RA, Jose PA (2004) Functional genomics of the dopaminergic system in hypertension. Physiol Genomics 19:233\u2013246","journal-title":"Physiol Genomics"},{"key":"347_CR259","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/ki.2008.247","volume":"74","author":"C Zeng","year":"2008","unstructured":"Zeng C, Asico LD, Yu C, Villar VA, Shi W, Luo Y, Wang Z, He D, Liu Y, Huang L, Yang C, Wang X, Hopfer U, Eisner GM, Jose PA (2008) Renal D3 dopamine receptor stimulation induces natriuresis by endothelin B receptor interactions. Kidney Int 74:750\u2013759","journal-title":"Kidney Int"},{"key":"347_CR260","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/1744-8069-4-57","volume":"4","author":"D Zhang","year":"2008","unstructured":"Zhang D, Zhang H, Jin GZ, Zhang K, Zhen X (2008) Single dose of morphine produced a prolonged effect on dopamine neuron activities. Mol Pain 4:57","journal-title":"Mol Pain"},{"key":"347_CR261","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s11064-011-0690-0","volume":"37","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Zhang F, Yang C, Jin H, Yang Y, Xu M (2012) Dopamine affects the change of pain-related electrical activity induced by morphine dependence. Neurochem Res 37:977\u2013982","journal-title":"Neurochem Res"},{"key":"347_CR262","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1016\/j.bbamem.2016.06.021","volume":"1858","author":"X Zhang","year":"2016","unstructured":"Zhang X, Le HT, Zhang X, Zheng M, Choi BG, Kim KM (2016a) Palmitoylation on the carboxyl terminus tail is required for the selective regulation of dopamine D2 versus D3 receptors. Biochim Biophys Acta 1858:2152\u20132162","journal-title":"Biochim Biophys Acta"},{"key":"347_CR263","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.bbrc.2016.05.104","volume":"476","author":"X Zhang","year":"2016","unstructured":"Zhang X, Sun N, Zheng M, Kim KM (2016b) Clathrin-mediated endocytosis is responsible for the lysosomal degradation of dopamine D3 receptor. Biochem Biophys Res Commun 476:245\u2013251","journal-title":"Biochem Biophys Res Commun"},{"key":"347_CR264","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/add.12698","volume":"110","author":"X Zhou","year":"2015","unstructured":"Zhou X, Qin B, Del Giovane C, Pan J, Gentile S, Liu Y, Lan X, Yu J, Xie P (2015) Efficacy and tolerability of antidepressants in the treatment of adolescents and young adults with depression and substance use disorders: a systematic review and meta-analysis. Addiction 110:38\u201348","journal-title":"Addiction"}],"container-title":["Current Topics in Behavioral Neurosciences","Therapeutic Applications of Dopamine D3 Receptor Function"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/7854_2022_347","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T11:52:25Z","timestamp":1727178745000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/7854_2022_347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9783031230578","9783031230585"],"references-count":264,"URL":"https:\/\/doi.org\/10.1007\/7854_2022_347","relation":{},"ISSN":["1866-3370","1866-3389"],"issn-type":[{"value":"1866-3370","type":"print"},{"value":"1866-3389","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"12 May 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}